data_2mwc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mwc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.429 ' CD2' ' H ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' VAL . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.422 HD21 ' NH1' ' A' ' 69' ' ' ARG . 65.4 t30 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.634 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.654 0.264 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' CD2' ' C ' ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 7.6 p-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.472 0.177 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.412 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' CB ' HD22 ' A' ' 67' ' ' ASN . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 66' ' ' LYS . 10.8 p30 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 40' ' ' ASP . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.595 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' OE1' ' OG ' ' A' ' 47' ' ' SER . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.597 ' HG ' ' N ' ' A' ' 91' ' ' VAL . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.583 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.532 ' C ' ' HG ' ' A' ' 86' ' ' SER . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.532 ' HG ' ' C ' ' A' ' 85' ' ' THR . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' N ' ' HG ' ' A' ' 73' ' ' SER . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 9.5 p-80 . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.423 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.613 ' NH1' ' HG ' ' A' ' 86' ' ' SER . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.613 ' HG ' ' NH1' ' A' ' 75' ' ' ARG . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' ' C ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.599 ' HG1' ' H ' ' A' ' 47' ' ' SER . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.639 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.431 ' ND2' ' NE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' NE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 ' N ' ' CD2' ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.658 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.698 HD22 HH21 ' A' ' 69' ' ' ARG . 59.4 t30 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.698 HH21 HD22 ' A' ' 67' ' ' ASN . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.623 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 120.621 0.248 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 . . . . . 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.683 0.278 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.633 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' OE1' ' OG1' ' A' ' 90' ' ' THR . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.588 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 53' ' ' VAL . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HZ1' ' CG ' ' A' ' 48' ' ' GLU . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.639 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.405 ' OG1' ' OE1' ' A' ' 14' ' ' GLU . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.835 0.35 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.403 ' C ' ' OD1' ' A' ' 49' ' ' ASN . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.553 ' H ' ' C ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.419 HD21 ' H ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.419 ' H ' HD21 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.433 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 29' ' ' GLN . 14.9 tm-20 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.451 ' C ' ' HG ' ' A' ' 86' ' ' SER . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' C ' ' A' ' 85' ' ' THR . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 78' ' ' PHE . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.589 ' H ' ' C ' ' A' ' 81' ' ' GLY . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.522 0.201 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' H ' ' HB ' ' A' ' 85' ' ' THR . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.587 ' C ' ' H ' ' A' ' 31' ' ' GLU . 7.5 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.459 -0.019 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.607 ' H ' ' C ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.684 0.278 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 5' ' ' THR . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.085 0.469 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' H ' ' CD1' ' A' ' 39' ' ' LEU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.591 ' HG ' ' H ' ' A' ' 48' ' ' GLU . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.591 ' H ' ' HG ' ' A' ' 47' ' ' SER . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.7 m120 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HG ' ' H ' ' A' ' 75' ' ' ARG . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' H ' ' HG ' ' A' ' 74' ' ' CYS . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' H ' ' HG1' ' A' ' 85' ' ' THR . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.642 ' H ' ' C ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 10' ' ' LEU . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.587 0.232 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.58 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.7 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.679 ' HG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.679 ' N ' ' HG1' ' A' ' 46' ' ' THR . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.593 ' H ' ' C ' ' A' ' 81' ' ' GLY . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.736 ' HG ' ' H ' ' A' ' 48' ' ' GLU . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.736 ' H ' ' HG ' ' A' ' 47' ' ' SER . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.614 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.555 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' H ' ' HB ' ' A' ' 85' ' ' THR . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.554 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.568 ' H ' ' C ' ' A' ' 81' ' ' GLY . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.503 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.73 -43.47 0.59 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.01 123.46 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.0 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.429 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -148.84 154.81 40.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.95 111.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.31 -39.9 4.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.841 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -169.87 112.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.03 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.407 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 20.6 m80 -135.82 128.73 31.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' VAL . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.422 HD21 ' NH1' ' A' ' 69' ' ' ARG . 65.4 t30 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.634 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -75.55 161.53 29.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.5 -158.4 9.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.48 -60.07 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 9.9 mp -79.81 140.35 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -77.36 -20.07 55.33 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.638 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -150.06 163.67 37.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.544 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -150.13 142.48 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.856 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -113.47 14.12 19.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.632 ' CE1' ' HD1' ' A' ' 101' ' ' HIS . 86.2 t60 -102.12 108.71 20.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.632 ' HD1' ' CE1' ' A' ' 100' ' ' HIS . 76.1 m80 44.11 86.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.649 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.651 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.35 -12.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.407 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp -166.55 120.71 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' CD2' ' C ' ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -147.56 134.31 20.03 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 p -122.79 116.3 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 110.712 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.9 0.07 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.279 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.39 118.65 3.64 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.709 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 7.6 p-80 -151.41 136.26 17.26 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.412 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' CB ' HD22 ' A' ' 67' ' ' ASN . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 66' ' ' LYS . 10.8 p30 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 40' ' ' ASP . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.595 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -80.84 167.58 19.75 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.71 -142.12 4.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.91 101.46 0.2 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 95' ' ' LEU . 10.4 mp -97.78 -5.0 35.85 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -88.19 132.61 34.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -154.01 9.17 0.37 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -106.05 103.32 12.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -150.91 166.38 30.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.21 -114.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.876 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.408 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 9.1 p80 -61.86 126.32 26.94 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.764 -179.789 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.61 -29.2 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.288 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -172.52 124.06 0.47 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.407 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 -110.51 -168.74 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 p 160.15 111.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.39 -52.59 3.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.988 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.47 132.52 56.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.308 0.575 . . . . 0.0 111.884 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 -154.4 139.05 16.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.765 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' OE1' ' OG ' ' A' ' 47' ' ' SER . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.597 ' HG ' ' N ' ' A' ' 91' ' ' VAL . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.59 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.583 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.532 ' C ' ' HG ' ' A' ' 86' ' ' SER . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.532 ' HG ' ' C ' ' A' ' 85' ' ' THR . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' N ' ' HG ' ' A' ' 73' ' ' SER . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -124.83 159.21 31.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.03 99.35 0.18 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.27 123.92 6.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.933 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.93 128.92 55.05 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.61 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.843 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -156.48 -43.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.4 m170 -111.11 138.65 47.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.989 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -111.75 113.41 25.76 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 95.0 m-70 -98.0 94.95 7.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.024 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 100' ' ' HIS . 30.1 m80 53.17 112.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.129 -179.768 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.55 -30.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.304 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? -158.16 115.14 2.88 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.19 139.72 20.56 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -123.63 118.46 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.026 0.441 . . . . 0.0 110.335 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.63 -0.06 40.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.883 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.44 111.17 1.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.618 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 9.5 p-80 -147.61 134.03 19.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.423 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.613 ' NH1' ' HG ' ' A' ' 86' ' ' SER . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.613 ' HG ' ' NH1' ' A' ' 75' ' ' ARG . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.69 164.19 24.8 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 -142.26 11.94 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.38 -175.38 26.36 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.6 mp -112.47 125.86 54.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -97.42 117.75 32.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.893 0.377 . . . . 0.0 110.423 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.89 -3.93 17.2 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 11.57 25.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.094 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -82.44 7.15 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.465 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.07 -54.41 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -155.34 89.6 1.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.942 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.88 -40.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.104 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp -165.58 124.26 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.503 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -146.73 134.99 21.75 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 2.5 m -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.46 0.648 . . . . 0.0 111.515 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.07 0.41 40.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.584 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.41 109.8 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.095 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.54 134.21 43.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' ' C ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 -99.53 137.98 37.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.41 -23.82 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.49 120.95 5.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.86 135.43 42.33 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -84.19 -10.42 57.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.935 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -90.27 6.59 42.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -80.17 129.65 34.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -125.61 118.13 25.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.984 0.421 . . . . 0.0 110.322 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.473 ' C ' ' H ' ' A' ' 102' ' ' HIS . 75.5 t60 -106.32 15.48 26.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.233 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 81.8 t60 47.2 15.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.502 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.473 ' H ' ' C ' ' A' ' 100' ' ' HIS . 51.2 t-80 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.414 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 -39.53 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.27 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.47 137.12 4.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.5 133.22 16.87 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.68 169.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.86 0.838 . . . . 0.0 113.198 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 -40.34 5.42 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.13 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.44 127.32 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -153.32 132.82 12.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.599 ' HG1' ' H ' ' A' ' 47' ' ' SER . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.639 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' ND2' ' NE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' NE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 ' N ' ' CD2' ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -112.72 149.55 32.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.63 -136.36 8.64 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.72 119.34 5.06 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.9 tp -121.25 120.65 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.72 0.295 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -144.75 35.93 1.16 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.65 55.96 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.2 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.432 ' N ' ' ND1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -155.82 159.99 39.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.099 179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -112.24 77.72 1.07 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -81.36 132.16 35.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.114 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -56.19 153.5 9.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.7 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.807 -179.668 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.779 0.323 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.56 -38.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.121 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.7 126.98 1.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.303 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 -149.24 167.49 25.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 m -137.66 123.2 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.39 -37.21 5.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.671 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.51 122.75 0.89 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.165 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.48 130.53 20.64 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.658 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.698 HD22 HH21 ' A' ' 69' ' ' ARG . 59.4 t30 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.698 HH21 HD22 ' A' ' 67' ' ' ASN . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.623 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 -98.47 131.42 44.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.87 -175.69 50.05 Favored Glycine 0 N--CA 1.465 0.623 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.07 -69.33 0.06 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.4 mt -114.08 131.6 56.33 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.88 -91.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -155.56 -46.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.803 0.335 . . . . 0.0 111.554 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 98' ' ' HIS . 42.7 p-80 -137.16 59.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -91.42 -10.45 40.98 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.434 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 82.3 t60 -145.44 159.92 42.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.463 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.527 ' N ' ' HD1' ' A' ' 101' ' ' HIS . 6.9 p-80 -155.51 159.35 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.079 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.479 ' C ' ' HD1' ' A' ' 102' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.84 -31.29 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.458 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -165.0 127.02 2.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.36 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -151.25 140.89 21.72 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 p -117.15 111.17 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.17 1.55 22.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.085 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.75 101.89 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -154.62 154.04 32.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.715 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.633 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -92.16 128.71 38.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.63 14.65 0.15 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.57 53.18 4.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.1 tp -106.9 -38.6 6.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -91.31 145.83 24.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.839 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -88.93 101.93 14.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -101.28 49.83 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.182 0.515 . . . . 0.0 110.624 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -116.24 15.76 15.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -75.79 -46.38 30.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.783 0.325 . . . . 0.0 110.496 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.07 157.44 46.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.617 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.84 1.72 0.01 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.876 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -163.64 124.99 2.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.346 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' OE1' ' OG1' ' A' ' 90' ' ' THR . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -148.9 135.25 19.38 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.68 149.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.774 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.23 -35.8 5.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.277 -1.328 . . . . 0.0 108.953 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.94 121.45 1.05 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 130.91 44.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.588 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.52 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 53' ' ' VAL . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HZ1' ' CG ' ' A' ' 48' ' ' GLU . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.639 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.405 ' OG1' ' OE1' ' A' ' 14' ' ' GLU . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.96 174.07 10.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.52 -168.72 45.1 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.07 -154.69 7.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.9 92.56 2.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.93 134.97 33.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.451 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -124.62 7.75 8.24 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -117.14 138.04 51.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.702 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -89.84 175.03 7.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -122.92 121.12 35.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 83.6 t60 43.03 26.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.46 ' OXT' ' O ' ' A' ' 101' ' ' HIS . 88.0 m-70 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 117.889 -1.053 . . . . 0.0 111.35 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.75 -38.53 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.741 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -169.24 139.07 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -149.86 134.44 17.54 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -128.26 123.87 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.376 0.608 . . . . 0.0 110.519 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.47 0.78 28.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.99 116.14 2.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.245 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.81 129.36 9.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.403 ' C ' ' OD1' ' A' ' 49' ' ' ASN . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 81' ' ' GLY . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.553 ' H ' ' C ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.419 HD21 ' H ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.419 ' H ' HD21 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.34 159.45 31.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.81 -152.84 8.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.96 101.8 2.62 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.28 -31.0 11.57 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.795 -0.238 . . . . 0.0 110.457 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -90.89 116.27 28.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -79.43 153.56 29.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -113.53 148.24 36.45 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.947 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -149.27 166.47 28.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.412 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.626 ' CE1' ' HD1' ' A' ' 101' ' ' HIS . 54.0 t-80 -135.56 108.03 7.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.434 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.626 ' HD1' ' CE1' ' A' ' 100' ' ' HIS . 77.5 m80 42.27 85.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.154 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 t60 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.953 179.613 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 -37.7 0.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.674 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -162.87 123.05 2.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 32' ' ' VAL . 14.9 tm-20 -150.13 153.14 35.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CD ' ' A' ' 31' ' ' GLU . 2.4 m -133.63 117.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.39 -38.69 5.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.328 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.51 120.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -136.28 130.63 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.451 ' C ' ' HG ' ' A' ' 86' ' ' SER . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HG ' ' C ' ' A' ' 85' ' ' THR . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -93.44 131.35 38.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.95 0.8 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.87 -174.71 47.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.1 mm? -108.2 124.29 50.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -79.91 117.85 21.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.937 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.41 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 84.0 t60 -158.22 -3.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.427 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -139.7 5.5 2.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -122.8 47.41 1.96 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -83.98 -119.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 110.804 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.8 -46.91 80.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.941 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.58 -39.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.855 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.27 123.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.201 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 -135.96 162.14 33.7 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 5.9 p 156.74 111.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.892 0.745 . . . . 0.0 110.331 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.13 -44.04 5.09 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.4 141.97 50.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 165.51 36.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.5 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 78' ' ' PHE . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.589 ' H ' ' C ' ' A' ' 81' ' ' GLY . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -122.75 158.03 31.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.2 124.17 8.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.01 163.99 28.37 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.8 -68.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 110.204 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.88 -88.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.078 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -149.47 137.47 20.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.55 123.76 21.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.774 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -97.17 132.62 42.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 11.6 p80 -88.13 107.63 18.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 51.04 99.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.482 ' H2 ' ' CD ' ' A' ' 31' ' ' GLU . 58.7 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 -39.5 0.73 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.539 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -174.92 136.63 0.4 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.538 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' H ' ' HB ' ' A' ' 85' ' ' THR . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.587 ' C ' ' H ' ' A' ' 31' ' ' GLU . 7.5 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 -151.91 161.81 42.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 m -134.94 125.81 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.25 -38.13 5.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.3 127.42 1.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.171 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.2 OUTLIER -154.04 128.03 8.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.607 ' H ' ' C ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -84.29 122.42 28.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.13 126.9 2.44 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -97.05 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.04 134.11 35.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -77.04 -35.84 56.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.713 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -121.29 97.42 5.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -105.2 -22.93 12.98 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -140.87 137.59 33.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.325 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.646 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 3.3 p80 -147.99 -102.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.777 0.323 . . . . 0.0 110.994 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.646 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 52.3 t-80 36.34 67.15 0.33 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.712 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.567 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -37.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.293 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -167.18 132.57 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 5' ' ' THR . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.85 134.77 19.01 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.92 121.66 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.036 0.446 . . . . 0.0 110.666 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.07 22.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.907 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.08 110.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -149.89 128.98 12.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -119.01 153.48 34.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.71 150.74 21.91 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.22 148.55 29.86 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.42 -34.9 6.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.872 0.368 . . . . 0.0 110.263 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 55.8 mp0 -84.78 123.14 30.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.52 -36.44 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.52 163.41 40.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -80.06 -69.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.464 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -160.67 140.36 10.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.523 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 46.9 p-80 -138.82 128.8 25.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.951 0.405 . . . . 0.0 110.522 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 101' ' ' HIS . 61.7 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.559 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.46 3.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.898 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -124.64 145.43 49.65 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 -150.19 149.5 30.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 m -128.2 115.13 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.93 -40.32 4.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.588 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.83 127.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.76 136.0 14.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' H ' ' CD1' ' A' ' 39' ' ' LEU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.591 ' HG ' ' H ' ' A' ' 48' ' ' GLU . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.591 ' H ' ' HG ' ' A' ' 47' ' ' SER . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.7 m120 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HG ' ' H ' ' A' ' 75' ' ' ARG . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' H ' ' HG ' ' A' ' 74' ' ' CYS . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -82.68 170.93 14.57 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.5 -107.76 0.92 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.9 129.27 9.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -92.07 -50.88 5.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.283 0.541 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -144.8 -139.24 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -82.53 152.89 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -134.94 144.53 47.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.4 123.75 33.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -133.87 132.45 40.34 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 102' ' ' HIS . 15.5 t-80 -96.95 118.21 32.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.836 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 101' ' ' HIS . 44.1 t60 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.843 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.88 -35.78 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -169.61 115.71 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.036 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' H ' ' HG1' ' A' ' 85' ' ' THR . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 -146.18 168.77 20.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.08 113.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.897 0.379 . . . . 0.0 109.996 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.0 -38.84 4.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.04 128.59 1.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -151.79 128.87 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.764 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.642 ' H ' ' C ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 10' ' ' LEU . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -88.18 129.5 35.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.02 165.74 53.62 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.05 -71.73 1.3 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.0 mm? -85.02 162.55 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -78.29 -17.44 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.182 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -93.73 127.66 39.56 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.016 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -87.6 127.62 35.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 111.183 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -134.55 111.9 10.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.0 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -121.11 143.74 48.93 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.836 0.35 . . . . 0.0 110.469 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -69.76 173.34 6.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.496 179.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.73 -25.73 1.25 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -167.35 121.07 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.906 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.58 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.7 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 -144.87 171.4 14.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 7.1 p 151.88 115.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 124.371 1.044 . . . . 0.0 109.928 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.91 -51.56 5.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.856 0.36 . . . . 0.0 110.082 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.68 146.05 47.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.572 0.701 . . . . 0.0 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -154.9 149.07 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.543 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.679 ' HG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.679 ' N ' ' HG1' ' A' ' 46' ' ' THR . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.622 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.593 ' H ' ' C ' ' A' ' 81' ' ' GLY . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -104.31 140.66 37.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.85 56.86 0.42 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.33 -88.6 0.76 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.7 tp -104.93 123.32 47.55 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -92.12 -21.1 20.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.74 125.34 34.83 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.24 -67.15 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.634 ' HD1' ' HD1' ' A' ' 100' ' ' HIS . 2.8 p80 -158.59 -46.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.773 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.634 ' HD1' ' HD1' ' A' ' 99' ' ' HIS . 75.2 m80 -129.08 149.12 51.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.625 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -151.86 157.88 42.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.492 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.46 ' H3 ' ' H ' ' A' ' 2' ' ' ALA . 9.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' H ' ' H3 ' ' A' ' 1' ' ' THR . . . -160.51 -2.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -124.13 147.86 47.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.307 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' C ' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -148.76 131.81 16.28 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.33 149.05 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.822 0.82 . . . . 0.0 112.594 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.54 -40.33 4.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' C ' ' HD1' ' A' ' 35' ' ' HIS . . . -168.4 117.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.412 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.454 ' HD1' ' C ' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -131.5 133.47 45.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -178.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.736 ' HG ' ' H ' ' A' ' 48' ' ' GLU . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.736 ' H ' ' HG ' ' A' ' 47' ' ' SER . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.614 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -108.25 143.0 37.68 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.96 130.86 2.77 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.261 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.8 101.75 2.83 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.1 mt -108.07 -18.33 13.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.07 120.0 27.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.816 0.341 . . . . 0.0 110.813 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -80.38 -66.37 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.22 95.66 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.198 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -112.69 -32.92 6.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.935 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.503 ' C ' ' HD1' ' A' ' 100' ' ' HIS . 1.1 p80 -85.27 169.52 13.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -134.61 153.08 52.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.458 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.603 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.405 ' H1 ' ' CD ' ' A' ' 31' ' ' GLU . 76.8 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.68 -41.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -159.46 122.27 3.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.248 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.555 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' H ' ' HB ' ' A' ' 85' ' ' THR . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' CD ' ' H1 ' ' A' ' 1' ' ' THR . 77.7 tt0 -104.78 162.21 13.5 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 p 161.45 110.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 123.821 0.7 . . . . 0.0 109.841 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.36 -43.75 5.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.781 -0.191 . . . . 0.0 111.074 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.77 141.7 51.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 111.27 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.18 159.79 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.304 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.554 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.568 ' H ' ' C ' ' A' ' 81' ' ' GLY . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 -105.69 142.25 35.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.77 20.77 6.76 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.73 159.8 40.57 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.5 tp -87.17 -75.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.859 0.362 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -78.71 144.0 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -108.37 124.01 49.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.333 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.69 -35.48 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.338 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.429 ' NE2' ' NH1' ' A' ' 92' ' ' ARG . 6.0 p80 -83.09 162.74 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.691 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.17 147.32 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.604 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -110.01 118.1 35.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.371 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.445 ' OXT' ' CD2' ' A' ' 102' ' ' HIS . 75.5 t60 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.414 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.93 -45.61 0.72 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 110.643 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -169.98 131.44 1.04 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.682 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.545 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 -149.19 162.19 40.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.78 118.15 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.18 -42.15 4.01 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.127 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -167.71 124.09 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.461 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 63.5 m80 -147.52 131.16 16.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.495 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.503 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.503 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.63 153.76 28.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.94 13.01 7.22 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.13 51.32 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.621 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.6 mt -85.71 -154.27 0.2 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.662 0.268 . . . . 0.0 111.32 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 96' ' ' GLU . 55.1 mp0 -77.89 124.63 28.23 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.514 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -77.44 -44.69 28.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.312 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.451 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 86.1 t60 -149.69 -1.48 0.44 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.574 0.226 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -82.18 111.83 18.65 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.29 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -122.81 140.46 52.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -152.35 155.82 38.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.016 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.283 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' C ' HD13 ' A' ' 27' ' ' LEU . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.555 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 65' ' ' LEU . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' LYS . 4.9 t-20 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 90' ' ' THR . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.636 ' N ' HD13 ' A' ' 89' ' ' LEU . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.654 0.264 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' CA ' HD12 ' A' ' 68' ' ' LEU . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 7.6 p-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.472 0.177 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' CA ' ' A' ' 19' ' ' GLY . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.561 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 28' ' ' SER . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD1' ' OE1' ' A' ' 42' ' ' GLU . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.485 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 80' ' ' ALA . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.528 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.556 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.4 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 76' ' ' VAL . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 ' HB1' ' A' ' 21' ' ' ALA . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 27' ' ' LEU . 46.7 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 9.5 p-80 . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 62' ' ' LEU . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 55' ' ' PHE . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 91' ' ' VAL . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 10' ' ' LEU . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 79' ' ' LEU . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 68' ' ' LEU . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HG2' ' A' ' 83' ' ' MET . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.738 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.5 m-20 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 62' ' ' LEU . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 55' ' ' PHE . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 39' ' ' LEU . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 35' ' ' HIS . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 54' ' ' PHE . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.445 ' ND2' ' HE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.894 ' N ' HD23 ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 21' ' ' ALA . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' OE2' HD11 ' A' ' 64' ' ' LEU . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 76' ' ' VAL . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.8 pt20 -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.644 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 65' ' ' LEU . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.609 HD11 ' OE2' ' A' ' 20' ' ' GLU . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 HD11 ' A' ' 63' ' ' LEU . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.416 ' HA ' HD21 ' A' ' 67' ' ' ASN . 1.5 t-20 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.588 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 120.621 0.248 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 6.4 p-10 -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 83' ' ' MET . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 . . . . . 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.683 0.278 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.56 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.591 ' C ' HD12 ' A' ' 62' ' ' LEU . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 63' ' ' LEU . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m120 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 79' ' ' LEU . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.598 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD23 ' A' ' 79' ' ' LEU . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD11 ' NE2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.484 ' NE2' HD11 ' A' ' 27' ' ' LEU . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.1 m170 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 63' ' ' LEU . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.528 ' C ' HD12 ' A' ' 62' ' ' LEU . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.673 HD11 HG21 ' A' ' 44' ' ' VAL . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 63' ' ' LEU . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 76' ' ' VAL . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.617 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.835 0.35 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 17' ' ' GLU . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 16' ' ' LEU . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.839 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.913 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.532 ' C ' HD12 ' A' ' 62' ' ' LEU . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 63' ' ' LEU . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CB ' HD21 ' A' ' 68' ' ' LEU . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.413 HD21 ' CB ' ' A' ' 65' ' ' LEU . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.792 ' N ' HD23 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 89' ' ' LEU . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 17' ' ' GLU . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' GLU . 44.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' GLN . 14.9 tm-20 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CG ' HG11 ' A' ' 44' ' ' VAL . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 61' ' ' HIS . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.533 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 ' CE ' ' A' ' 83' ' ' MET . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 63' ' ' LEU . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 52' ' ' VAL . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 83' ' ' MET . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.522 0.201 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 83' ' ' MET . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 28' ' ' SER . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.747 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.567 ' C ' ' H ' ' A' ' 31' ' ' GLU . 42.8 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.459 -0.019 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 61' ' ' HIS . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' C ' HD23 ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 63' ' ' LEU . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 79' ' ' LEU . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.684 0.278 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CZ ' HG21 ' A' ' 13' ' ' VAL . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 28' ' ' SER . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.636 ' HB3' HD21 ' A' ' 27' ' ' LEU . 51.9 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.085 0.469 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.634 ' C ' HD12 ' A' ' 62' ' ' LEU . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 21' ' ' ALA . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD13 HG12 ' A' ' 76' ' ' VAL . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 42' ' ' GLU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' ALA . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 64' ' ' LEU . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 10' ' ' LEU . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 79' ' ' LEU . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 83' ' ' MET . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 44' ' ' VAL . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 24' ' ' GLU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 HG11 ' A' ' 44' ' ' VAL . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 64' ' ' LEU . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.631 ' N ' ' O ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.587 0.232 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.531 ' C ' HD13 ' A' ' 27' ' ' LEU . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 31' ' ' GLU . 5.0 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.631 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' ND1' HD11 ' A' ' 27' ' ' LEU . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.768 ' N ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 65' ' ' LEU . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.562 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' N ' ' HE3' ' A' ' 83' ' ' MET . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.716 HD21 ' SG ' ' A' ' 25' ' ' CYS . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB3' HD22 ' A' ' 10' ' ' LEU . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.716 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.5 m170 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.591 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 37' ' ' TRP . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.584 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.42 ' C ' HD13 ' A' ' 27' ' ' LEU . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 44' ' ' VAL . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 65' ' ' LEU . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 25' ' ' CYS . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 91' ' ' VAL . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' C ' ' A' ' 21' ' ' ALA . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' HD13 ' A' ' 27' ' ' LEU . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' VAL . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 52' ' ' VAL . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.963 ' N ' HD23 ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 15' ' ' ALA . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.73 -43.47 0.59 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.01 123.46 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.0 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' C ' HD13 ' A' ' 27' ' ' LEU . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -148.84 154.81 40.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.95 111.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.31 -39.9 4.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.841 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -169.87 112.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.03 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.407 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 20.6 m80 -135.82 128.73 31.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.555 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 65' ' ' LEU . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' LYS . 4.9 t-20 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 90' ' ' THR . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.636 ' N ' HD13 ' A' ' 89' ' ' LEU . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -75.55 161.53 29.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.5 -158.4 9.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.48 -60.07 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.9 mp -79.81 140.35 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -77.36 -20.07 55.33 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.638 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -150.06 163.67 37.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.544 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -150.13 142.48 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.856 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -113.47 14.12 19.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -102.12 108.71 20.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 76.1 m80 44.11 86.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.649 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.651 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.35 -12.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.407 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp -166.55 120.71 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' CA ' HD12 ' A' ' 68' ' ' LEU . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -147.56 134.31 20.03 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 34' ' ' ALA . 3.8 p -122.79 116.3 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 110.712 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.9 0.07 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.279 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -157.39 118.65 3.64 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.709 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 7.6 p-80 -151.41 136.26 17.26 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' CA ' ' A' ' 19' ' ' GLY . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.561 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -80.84 167.58 19.75 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.71 -142.12 4.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.91 101.46 0.2 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.4 mp -97.78 -5.0 35.85 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -88.19 132.61 34.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -154.01 9.17 0.37 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -106.05 103.32 12.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -150.91 166.38 30.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.21 -114.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.876 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -61.86 126.32 26.94 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.144 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.764 -179.789 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.61 -29.2 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.288 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -172.52 124.06 0.47 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 28' ' ' SER . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 -110.51 -168.74 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.2 p 160.15 111.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.39 -52.59 3.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.988 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.47 132.52 56.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.308 0.575 . . . . 0.0 111.884 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 -154.4 139.05 16.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.765 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD1' ' OE1' ' A' ' 42' ' ' GLU . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.485 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 80' ' ' ALA . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.556 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -124.83 159.21 31.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.03 99.35 0.18 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.27 123.92 6.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.933 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.93 128.92 55.05 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.61 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.843 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -156.48 -43.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.4 m170 -111.11 138.65 47.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.989 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -111.75 113.41 25.76 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 95.0 m-70 -98.0 94.95 7.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.024 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 100' ' ' HIS . 30.1 m80 53.17 112.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.129 -179.768 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.55 -30.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.304 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? -158.16 115.14 2.88 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 76' ' ' VAL . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 ' HB1' ' A' ' 21' ' ' ALA . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 27' ' ' LEU . 46.7 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.19 139.72 20.56 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.603 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.9 p -123.63 118.46 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.026 0.441 . . . . 0.0 110.335 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.63 -0.06 40.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.883 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -161.44 111.17 1.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 9.5 p-80 -147.61 134.03 19.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 62' ' ' LEU . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 55' ' ' PHE . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 91' ' ' VAL . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 10' ' ' LEU . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 79' ' ' LEU . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 68' ' ' LEU . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.69 164.19 24.8 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 -142.26 11.94 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -155.38 -175.38 26.36 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 94' ' ' GLY . 10.6 mp -112.47 125.86 54.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -97.42 117.75 32.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.893 0.377 . . . . 0.0 110.423 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.89 -3.93 17.2 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 11.57 25.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.094 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -82.44 7.15 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.465 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.07 -54.41 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -155.34 89.6 1.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.942 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.88 -40.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.104 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp -165.58 124.26 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.503 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HG2' ' A' ' 83' ' ' MET . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -146.73 134.99 21.75 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.5 m -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.46 0.648 . . . . 0.0 111.515 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.07 0.41 40.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.584 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.41 109.8 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.095 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.738 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -133.54 134.21 43.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.5 m-20 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 62' ' ' LEU . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 55' ' ' PHE . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 39' ' ' LEU . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 35' ' ' HIS . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 -99.53 137.98 37.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.41 -23.82 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.49 120.95 5.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.86 135.43 42.33 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -84.19 -10.42 57.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.935 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -90.27 6.59 42.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -80.17 129.65 34.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -125.61 118.13 25.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.984 0.421 . . . . 0.0 110.322 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.463 ' C ' ' N ' ' A' ' 102' ' ' HIS . 75.5 t60 -106.32 15.48 26.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.233 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 81.8 t60 47.2 15.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.502 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.463 ' N ' ' C ' ' A' ' 100' ' ' HIS . 51.2 t-80 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.414 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 -39.53 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.27 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.47 137.12 4.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.5 133.22 16.87 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.601 HG21 ' ND1' ' A' ' 35' ' ' HIS . 1.4 m -102.68 169.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.86 0.838 . . . . 0.0 113.198 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 -40.34 5.42 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.13 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.44 127.32 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.601 ' ND1' HG21 ' A' ' 32' ' ' VAL . 32.9 p-80 -153.32 132.82 12.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 54' ' ' PHE . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.445 ' ND2' ' HE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.894 ' N ' HD23 ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -112.72 149.55 32.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.63 -136.36 8.64 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.72 119.34 5.06 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.9 tp -121.25 120.65 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.72 0.295 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -144.75 35.93 1.16 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.65 55.96 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.2 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -155.82 159.99 39.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.099 179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -112.24 77.72 1.07 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -81.36 132.16 35.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.114 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -56.19 153.5 9.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.7 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.807 -179.668 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.779 0.323 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.56 -38.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.121 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.7 126.98 1.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.303 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 21' ' ' ALA . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' OE2' HD11 ' A' ' 64' ' ' LEU . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 76' ' ' VAL . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.8 pt20 -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 -149.24 167.49 25.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.0 m -137.66 123.2 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.39 -37.21 5.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.671 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.51 122.75 0.89 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.165 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.48 130.53 20.64 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.644 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 65' ' ' LEU . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.609 HD11 ' OE2' ' A' ' 20' ' ' GLU . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 HD11 ' A' ' 63' ' ' LEU . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.416 ' HA ' HD21 ' A' ' 67' ' ' ASN . 1.5 t-20 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.588 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 -98.47 131.42 44.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.87 -175.69 50.05 Favored Glycine 0 N--CA 1.465 0.623 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.07 -69.33 0.06 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.4 mt -114.08 131.6 56.33 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.88 -91.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -155.56 -46.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.803 0.335 . . . . 0.0 111.554 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 42.7 p-80 -137.16 59.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -91.42 -10.45 40.98 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.434 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 82.3 t60 -145.44 159.92 42.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.463 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.485 ' ND1' ' N ' ' A' ' 101' ' ' HIS . 6.9 p-80 -155.51 159.35 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.079 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.45 ' ND1' ' C ' ' A' ' 102' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.84 -31.29 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.458 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -165.0 127.02 2.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.36 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 6.4 p-10 -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 83' ' ' MET . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -151.25 140.89 21.72 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 32' ' ' VAL . 8.6 p -117.15 111.17 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.17 1.55 22.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.085 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.75 101.89 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -154.62 154.04 32.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.715 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.56 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.591 ' C ' HD12 ' A' ' 62' ' ' LEU . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 63' ' ' LEU . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.6 m120 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 79' ' ' LEU . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.598 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD23 ' A' ' 79' ' ' LEU . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -92.16 128.71 38.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.63 14.65 0.15 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.57 53.18 4.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.1 tp -106.9 -38.6 6.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -91.31 145.83 24.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.839 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -88.93 101.93 14.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -101.28 49.83 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.182 0.515 . . . . 0.0 110.624 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -116.24 15.76 15.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -75.79 -46.38 30.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.783 0.325 . . . . 0.0 110.496 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.07 157.44 46.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.617 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.84 1.72 0.01 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.876 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -163.64 124.99 2.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.346 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD11 ' NE2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.484 ' NE2' HD11 ' A' ' 27' ' ' LEU . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -148.9 135.25 19.38 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 ' ND1' ' A' ' 35' ' ' HIS . 7.5 p -73.68 149.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.774 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.23 -35.8 5.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.277 -1.328 . . . . 0.0 108.953 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.94 121.45 1.05 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.496 ' ND1' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.47 130.91 44.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 63' ' ' LEU . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.528 ' C ' HD12 ' A' ' 62' ' ' LEU . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.673 HD11 HG21 ' A' ' 44' ' ' VAL . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 63' ' ' LEU . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 76' ' ' VAL . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.617 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.96 174.07 10.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.52 -168.72 45.1 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.07 -154.69 7.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.9 92.56 2.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.93 134.97 33.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.451 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -124.62 7.75 8.24 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -117.14 138.04 51.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.702 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -89.84 175.03 7.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -122.92 121.12 35.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 54.7 t-80 43.03 26.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.46 ' OXT' ' O ' ' A' ' 101' ' ' HIS . 88.0 m-70 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 117.889 -1.053 . . . . 0.0 111.35 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.75 -38.53 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.741 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -169.24 139.07 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 17' ' ' GLU . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 16' ' ' LEU . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.839 HD22 ' N ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.913 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -149.86 134.44 17.54 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.8 p -128.26 123.87 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.376 0.608 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.47 0.78 28.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -158.99 116.14 2.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.245 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.81 129.36 9.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.532 ' C ' HD12 ' A' ' 62' ' ' LEU . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 63' ' ' LEU . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CB ' HD21 ' A' ' 68' ' ' LEU . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.413 HD21 ' CB ' ' A' ' 65' ' ' LEU . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.792 ' N ' HD23 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 89' ' ' LEU . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.34 159.45 31.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.81 -152.84 8.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.96 101.8 2.62 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.28 -31.0 11.57 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.795 -0.238 . . . . 0.0 110.457 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -90.89 116.27 28.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -79.43 153.56 29.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -113.53 148.24 36.45 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.947 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -149.27 166.47 28.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.412 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -135.56 108.03 7.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.434 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 42.27 85.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 t60 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.953 179.613 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 -37.7 0.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.674 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -162.87 123.05 2.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 17' ' ' GLU . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' GLU . 44.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 32' ' ' VAL . 14.9 tm-20 -150.13 153.14 35.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.4 m -133.63 117.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.39 -38.69 5.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.328 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.51 120.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -136.28 130.63 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CG ' HG11 ' A' ' 44' ' ' VAL . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 61' ' ' HIS . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.533 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -93.44 131.35 38.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.95 0.8 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.87 -174.71 47.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' N ' ' A' ' 95' ' ' LEU . 1.1 mm? -108.2 124.29 50.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -79.91 117.85 21.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.937 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.41 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 84.0 t60 -158.22 -3.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.427 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -139.7 5.5 2.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -122.8 47.41 1.96 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -83.98 -119.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 110.804 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.8 -46.91 80.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.941 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.58 -39.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.855 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.27 123.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.201 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 ' CE ' ' A' ' 83' ' ' MET . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 -135.96 162.14 33.7 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.9 p 156.74 111.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.892 0.745 . . . . 0.0 110.331 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.13 -44.04 5.09 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.4 141.97 50.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 165.51 36.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.5 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 63' ' ' LEU . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 52' ' ' VAL . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 83' ' ' MET . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -122.75 158.03 31.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.2 124.17 8.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.01 163.99 28.37 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.8 -68.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 110.204 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.88 -88.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.078 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -149.47 137.47 20.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.55 123.76 21.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.774 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -97.17 132.62 42.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.484 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 11.6 p80 -88.13 107.63 18.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 51.04 99.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 -39.5 0.73 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.539 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -174.92 136.63 0.4 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.538 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 83' ' ' MET . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 28' ' ' SER . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.747 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.567 ' C ' ' H ' ' A' ' 31' ' ' GLU . 42.8 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 -151.91 161.81 42.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 m -134.94 125.81 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.25 -38.13 5.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.3 127.42 1.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.171 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.04 128.03 8.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 61' ' ' HIS . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' C ' HD23 ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 63' ' ' LEU . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 79' ' ' LEU . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -84.29 122.42 28.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.13 126.9 2.44 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -97.05 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.9 mp -82.04 134.11 35.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -77.04 -35.84 56.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.713 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -121.29 97.42 5.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -105.2 -22.93 12.98 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -140.87 137.59 33.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.325 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 3.3 p80 -147.99 -102.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.777 0.323 . . . . 0.0 110.994 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 52.3 t-80 36.34 67.15 0.33 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.712 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.567 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 2' ' ' ALA . 90.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' N ' HG22 ' A' ' 1' ' ' THR . . . -151.83 -37.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.293 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -167.18 132.57 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CZ ' HG21 ' A' ' 13' ' ' VAL . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 28' ' ' SER . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.636 ' HB3' HD21 ' A' ' 27' ' ' LEU . 51.9 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.85 134.77 19.01 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 34' ' ' ALA . 2.5 p -125.92 121.66 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.036 0.446 . . . . 0.0 110.666 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.07 22.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.907 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.663 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -160.08 110.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.846 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -149.89 128.98 12.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.634 ' C ' HD12 ' A' ' 62' ' ' LEU . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 21' ' ' ALA . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -119.01 153.48 34.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.71 150.74 21.91 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.22 148.55 29.86 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.42 -34.9 6.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.872 0.368 . . . . 0.0 110.263 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 55.8 mp0 -84.78 123.14 30.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.52 -36.44 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.52 163.41 40.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -80.06 -69.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.464 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -160.67 140.36 10.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.523 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 46.9 p-80 -138.82 128.8 25.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.951 0.405 . . . . 0.0 110.522 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 101' ' ' HIS . 61.7 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.559 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 3' ' ' LYS . . . -173.46 3.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.898 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 2' ' ' ALA . 1.9 tmtm? -124.64 145.43 49.65 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD13 HG12 ' A' ' 76' ' ' VAL . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 -150.19 149.5 30.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.1 m -128.2 115.13 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.93 -40.32 4.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.588 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.83 127.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.76 136.0 14.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 42' ' ' GLU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' ALA . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 64' ' ' LEU . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 10' ' ' LEU . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.543 ' C ' HD23 ' A' ' 79' ' ' LEU . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -82.68 170.93 14.57 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.5 -107.76 0.92 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.9 129.27 9.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -92.07 -50.88 5.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.283 0.541 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -144.8 -139.24 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -82.53 152.89 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -134.94 144.53 47.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.4 123.75 33.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -133.87 132.45 40.34 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 102' ' ' HIS . 15.5 t-80 -96.95 118.21 32.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.836 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 101' ' ' HIS . 44.1 t60 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.843 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.88 -35.78 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -169.61 115.71 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.036 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 83' ' ' MET . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 -146.18 168.77 20.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 53.9 t -129.08 113.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.897 0.379 . . . . 0.0 109.996 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.0 -38.84 4.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.04 128.59 1.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -151.79 128.87 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.764 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 44' ' ' VAL . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 24' ' ' GLU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 HG11 ' A' ' 44' ' ' VAL . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 64' ' ' LEU . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m120 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.631 ' N ' ' O ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -88.18 129.5 35.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.02 165.74 53.62 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.05 -71.73 1.3 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 3.0 mm? -85.02 162.55 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -78.29 -17.44 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.182 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -93.73 127.66 39.56 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.016 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -87.6 127.62 35.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 111.183 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -134.55 111.9 10.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.0 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -121.11 143.74 48.93 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.836 0.35 . . . . 0.0 110.469 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -69.76 173.34 6.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.496 179.718 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.73 -25.73 1.25 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -167.35 121.07 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.906 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.531 ' C ' HD13 ' A' ' 27' ' ' LEU . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 31' ' ' GLU . 5.0 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 -144.87 171.4 14.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.1 p 151.88 115.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 124.371 1.044 . . . . 0.0 109.928 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.91 -51.56 5.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.856 0.36 . . . . 0.0 110.082 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.68 146.05 47.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.572 0.701 . . . . 0.0 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -154.9 149.07 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.543 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.631 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' ND1' HD11 ' A' ' 27' ' ' LEU . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.768 ' N ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 65' ' ' LEU . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 79' ' ' LEU . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.562 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -104.31 140.66 37.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.85 56.86 0.42 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.33 -88.6 0.76 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.7 tp -104.93 123.32 47.55 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -92.12 -21.1 20.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.74 125.34 34.83 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.24 -67.15 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -158.59 -46.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.773 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -129.08 149.12 51.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.625 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -151.86 157.88 42.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.492 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.51 -2.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -124.13 147.86 47.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.307 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' N ' ' HE3' ' A' ' 83' ' ' MET . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.716 HD21 ' SG ' ' A' ' 25' ' ' CYS . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB3' HD22 ' A' ' 10' ' ' LEU . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.716 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.458 HD12 ' C ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -148.76 131.81 16.28 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 35' ' ' HIS . 6.7 p -70.33 149.05 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.822 0.82 . . . . 0.0 112.594 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.54 -40.33 4.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' C ' ' HD1' ' A' ' 35' ' ' HIS . . . -168.4 117.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.412 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.581 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -131.5 133.47 45.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -178.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.591 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 37' ' ' TRP . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.584 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -108.25 143.0 37.68 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.96 130.86 2.77 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.261 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.8 101.75 2.83 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.1 mt -108.07 -18.33 13.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.07 120.0 27.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.816 0.341 . . . . 0.0 110.813 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -80.38 -66.37 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.22 95.66 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.198 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -112.69 -32.92 6.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.935 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 1.1 p80 -85.27 169.52 13.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -134.61 153.08 52.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.458 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.603 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.68 -41.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -159.46 122.27 3.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.248 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.42 ' C ' HD13 ' A' ' 27' ' ' LEU . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 77.7 tt0 -104.78 162.21 13.5 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.9 p 161.45 110.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 123.821 0.7 . . . . 0.0 109.841 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.36 -43.75 5.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.781 -0.191 . . . . 0.0 111.074 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.77 141.7 51.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 111.27 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.18 159.79 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.304 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 44' ' ' VAL . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 65' ' ' LEU . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 -105.69 142.25 35.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.77 20.77 6.76 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.73 159.8 40.57 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.5 tp -87.17 -75.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.859 0.362 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -78.71 144.0 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -108.37 124.01 49.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.333 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.69 -35.48 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.338 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 6.0 p80 -83.09 162.74 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.691 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.17 147.32 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.604 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -110.01 118.1 35.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.371 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.409 ' OXT' ' CG ' ' A' ' 102' ' ' HIS . 57.9 t-80 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.414 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.93 -45.61 0.72 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 110.643 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -169.98 131.44 1.04 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.682 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 25' ' ' CYS . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 91' ' ' VAL . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' C ' ' A' ' 21' ' ' ALA . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' HD13 ' A' ' 27' ' ' LEU . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' N ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 -149.19 162.19 40.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.78 118.15 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.18 -42.15 4.01 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.127 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -167.71 124.09 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.461 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 63.5 m80 -147.52 131.16 16.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.495 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' VAL . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 52' ' ' VAL . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.963 ' N ' HD23 ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 15' ' ' ALA . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.63 153.76 28.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.94 13.01 7.22 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.13 51.32 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.621 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.6 mt -85.71 -154.27 0.2 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.662 0.268 . . . . 0.0 111.32 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.1 mp0 -77.89 124.63 28.23 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.514 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -77.44 -44.69 28.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.312 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 98' ' ' HIS . 86.1 t60 -149.69 -1.48 0.44 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.574 0.226 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -82.18 111.83 18.65 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.29 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -122.81 140.46 52.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -152.35 155.82 38.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.016 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.283 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' C ' HD13 ' A' ' 27' ' ' LEU . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.881 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.555 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 65' ' ' LEU . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.452 HD22 ' NH1' ' A' ' 69' ' ' ARG . 65.4 t30 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 90' ' ' THR . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.636 ' N ' HD13 ' A' ' 89' ' ' LEU . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.654 0.264 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' CA ' HD12 ' A' ' 68' ' ' LEU . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.665 ' C ' HD23 ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 7.6 p-80 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.472 0.177 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.44 HD21 ' CB ' ' A' ' 49' ' ' ASN . 10.8 p30 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' CA ' ' A' ' 19' ' ' GLY . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 28' ' ' SER . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD1' ' OE1' ' A' ' 42' ' ' GLU . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.485 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 80' ' ' ALA . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.556 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 84' ' ' VAL . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.4 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 76' ' ' VAL . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 ' HB1' ' A' ' 21' ' ' ALA . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 27' ' ' LEU . 6.2 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 9.5 p-80 . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 62' ' ' LEU . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 55' ' ' PHE . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 91' ' ' VAL . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 10' ' ' LEU . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 79' ' ' LEU . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 68' ' ' LEU . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp . . . . . 0 N--CA 1.458 -0.069 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HG2' ' A' ' 83' ' ' MET . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.738 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 10.6 m120 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 62' ' ' LEU . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 55' ' ' PHE . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 39' ' ' LEU . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 35' ' ' HIS . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 54' ' ' PHE . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.445 ' ND2' ' HE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' VAL . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.894 ' N ' HD23 ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 21' ' ' ALA . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' OE2' HD11 ' A' ' 64' ' ' LEU . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 76' ' ' VAL . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.644 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 65' ' ' LEU . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.609 HD11 ' OE2' ' A' ' 20' ' ' GLU . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 HD11 ' A' ' 63' ' ' LEU . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.741 HD21 HH21 ' A' ' 69' ' ' ARG . 59.4 t30 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.741 HH21 HD21 ' A' ' 67' ' ' ASN . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.588 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 120.621 0.248 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 83' ' ' MET . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 . . . . . 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.683 0.278 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.56 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.591 ' C ' HD12 ' A' ' 62' ' ' LEU . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 63' ' ' LEU . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 79' ' ' LEU . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.598 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD23 ' A' ' 79' ' ' LEU . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD11 ' NE2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.484 ' NE2' HD11 ' A' ' 27' ' ' LEU . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 63' ' ' LEU . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.528 ' C ' HD12 ' A' ' 62' ' ' LEU . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.673 HD11 HG21 ' A' ' 44' ' ' VAL . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 63' ' ' LEU . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 76' ' ' VAL . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.617 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.835 0.35 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 17' ' ' GLU . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 16' ' ' LEU . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.839 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.913 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.532 ' C ' HD12 ' A' ' 62' ' ' LEU . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 63' ' ' LEU . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CB ' HD21 ' A' ' 68' ' ' LEU . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.413 HD21 ' CB ' ' A' ' 65' ' ' LEU . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.792 ' N ' HD23 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 89' ' ' LEU . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 17' ' ' GLU . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' GLN . 14.9 tm-20 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CG ' HG11 ' A' ' 44' ' ' VAL . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 61' ' ' HIS . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 84' ' ' VAL . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 ' CE ' ' A' ' 83' ' ' MET . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 63' ' ' LEU . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 52' ' ' VAL . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 83' ' ' MET . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.522 0.201 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 83' ' ' MET . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 28' ' ' SER . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.747 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.567 ' C ' ' H ' ' A' ' 31' ' ' GLU . 7.5 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.459 -0.019 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 61' ' ' HIS . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 63' ' ' LEU . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 79' ' ' LEU . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.684 0.278 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CZ ' HG21 ' A' ' 13' ' ' VAL . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 28' ' ' SER . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.636 ' HB3' HD21 ' A' ' 27' ' ' LEU . 6.7 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.085 0.469 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.634 ' C ' HD12 ' A' ' 62' ' ' LEU . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 21' ' ' ALA . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD13 HG12 ' A' ' 76' ' ' VAL . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 . . . . . 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 42' ' ' GLU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' ALA . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 64' ' ' LEU . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.7 m120 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 10' ' ' LEU . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 79' ' ' LEU . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 83' ' ' MET . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 44' ' ' VAL . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 24' ' ' GLU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 HG11 ' A' ' 44' ' ' VAL . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 64' ' ' LEU . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.631 ' N ' ' O ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.587 0.232 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.531 ' C ' HD13 ' A' ' 27' ' ' LEU . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.867 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.7 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.059 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.631 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' ND1' HD11 ' A' ' 27' ' ' LEU . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 65' ' ' LEU . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.562 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' N ' ' HE3' ' A' ' 83' ' ' MET . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.716 HD21 ' SG ' ' A' ' 25' ' ' CYS . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB3' HD22 ' A' ' 10' ' ' LEU . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.716 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.581 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.591 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 37' ' ' TRP . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 62' ' ' LEU . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.584 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.42 ' C ' HD13 ' A' ' 27' ' ' LEU . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.85 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 44' ' ' VAL . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 65' ' ' LEU . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 25' ' ' CYS . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 91' ' ' VAL . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' C ' ' A' ' 21' ' ' ALA . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' HD13 ' A' ' 27' ' ' LEU . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.826 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' VAL . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 52' ' ' VAL . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.963 ' N ' HD23 ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 15' ' ' ALA . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.73 -43.47 0.59 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.01 123.46 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.0 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -142.96 115.15 8.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 m -155.62 109.09 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.465 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.95 134.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.361 0.6 . . . . 0.0 110.583 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.01 -41.04 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.942 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -135.54 128.28 31.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.639 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.71 -170.68 38.87 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 85' ' ' THR . 15.2 mt -74.2 166.86 22.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -141.59 166.77 23.84 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.0 110.536 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 51.5 p30 -60.52 145.47 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.22 129.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -120.41 122.57 41.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.25 135.53 19.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.968 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -74.88 163.99 27.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.004 0.43 . . . . 0.0 110.339 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.68 142.67 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.323 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.13 22.99 78.63 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.93 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.29 -169.87 22.12 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -120.74 168.43 11.43 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.74 138.68 42.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.201 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mp -130.1 119.34 22.9 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.759 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -113.64 105.48 13.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.387 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.77 118.89 37.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.415 0.626 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -118.02 129.25 55.47 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.185 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' C ' HD13 ' A' ' 27' ' ' LEU . 37.0 tt0 -112.61 117.11 31.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.884 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.881 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.78 152.34 51.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.442 0.639 . . . . 0.0 111.181 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.9 t -92.69 96.04 9.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.05 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -173.28 82.18 0.4 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.8 41.36 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.325 2.017 . . . . 0.0 111.593 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -148.84 154.81 40.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.516 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -127.95 111.96 25.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.31 -39.9 4.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.841 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -169.87 112.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.03 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.407 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 20.6 m80 -135.82 128.73 31.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.664 0.268 . . . . 0.0 110.455 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.8 m -125.61 130.19 51.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.555 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -125.16 106.83 10.19 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.56 112.43 13.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.503 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -91.36 -107.31 0.1 Allowed 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 52.1 t0 -61.52 166.33 4.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.37 34.85 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 9.6 mp0 -128.37 137.63 31.3 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -55.05 132.66 53.65 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -87.59 84.14 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.989 0.899 . . . . 0.0 112.31 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 50' ' ' ALA . 74.4 ttt180 -147.77 -84.27 0.11 Allowed 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 55.94 -125.58 2.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.384 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 50' ' ' ALA . 43.6 m -135.23 -145.36 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.154 -0.342 . . . . 0.0 111.722 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 50' ' ' ALA . 80.4 mm-40 -57.57 -43.48 84.58 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.551 -0.718 . . . . 0.0 112.341 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 26.7 t-20 -60.85 1.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.507 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.62 131.21 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -179.7 144.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.62 142.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-O 121.345 0.593 . . . . 0.0 111.561 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.2 m -143.42 147.51 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.464 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.25 -173.14 3.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 59.2 28.08 17.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.655 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 66.24 35.13 6.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.422 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.73 66.15 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.904 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.09 -16.28 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.49 0.645 . . . . 0.0 109.657 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -134.52 91.49 2.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.236 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -81.41 115.0 20.54 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.5 tt -121.0 124.65 45.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.4 tp -114.1 121.76 44.8 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.307 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 65' ' ' LEU . 45.7 tp -112.16 128.63 56.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.949 0.404 . . . . 0.0 111.929 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 11.1 mp -111.91 -178.06 3.33 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ASN . 51.7 mtmt -158.44 176.48 12.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.958 0.345 . . . . 0.0 110.489 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.452 HD22 ' NH1' ' A' ' 69' ' ' ARG . 65.4 t30 33.91 47.0 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.022 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.26 113.6 2.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -88.32 157.77 49.98 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.07 -38.32 70.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.225 1.284 . . . . 0.0 109.181 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -50.87 -42.57 58.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.093 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 73' ' ' SER . 45.4 p-10 -43.95 -35.3 1.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.279 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.552 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.7 p -36.81 96.79 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.652 0.66 . . . . 0.0 110.285 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 72' ' ' ASP . 20.8 p -142.99 -161.99 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.389 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -104.61 134.37 47.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.591 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.7 109.33 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.6 m -123.52 127.87 48.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.022 0.439 . . . . 0.0 111.528 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 61.3 t80 -126.07 116.98 22.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.182 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.9 tp -114.11 92.39 3.95 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.115 0.484 . . . . 0.0 112.253 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -109.05 100.05 9.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.303 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 54.75 -166.33 2.66 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -52.75 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -123.42 130.14 52.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.41 127.63 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.275 0.559 . . . . 0.0 110.434 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.1 p -121.43 135.21 55.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.788 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t -148.38 132.35 17.17 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.723 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.86 46.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.292 0.567 . . . . 0.0 111.58 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -75.47 155.06 36.59 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.742 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 90' ' ' THR . 0.4 OUTLIER -113.73 125.65 54.36 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.636 ' N ' HD13 ' A' ' 89' ' ' LEU . 87.3 m -135.39 120.65 19.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -141.75 132.03 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.78 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -75.55 161.53 29.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.849 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.5 -158.4 9.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.48 -60.07 0.01 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 95' ' ' LEU . 9.9 mp -79.81 140.35 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -77.36 -20.07 55.33 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.638 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -150.06 163.67 37.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.544 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -150.13 142.48 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.856 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -113.47 14.12 19.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -102.12 108.71 20.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 76.1 m80 44.11 86.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.649 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.651 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.35 -12.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.407 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' NE2' ' A' ' 29' ' ' GLN . 35.2 tttp -166.55 120.71 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 111.1 8.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.5 m -140.16 111.57 7.22 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.463 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.83 135.01 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.51 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.55 -46.49 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 9' ' ' GLY . 57.1 ttm-85 -144.32 153.61 42.18 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.561 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.48 -143.37 11.32 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.837 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.1 mt -77.44 160.17 28.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.035 -0.582 . . . . 0.0 109.659 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -138.54 152.95 48.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 110.38 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.1 p-10 -58.07 147.05 30.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.68 132.25 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.014 0.435 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -127.06 118.06 23.67 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.04 150.09 29.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 0.0 110.311 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 16' ' ' LEU . 1.2 pt? -80.32 160.06 25.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.435 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -56.83 141.41 44.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.242 0.544 . . . . 0.0 111.89 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.16 82.45 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.791 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' CA ' HD12 ' A' ' 68' ' ' LEU . . . -97.28 -166.09 32.49 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -117.89 157.23 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.49 144.26 29.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.68 124.94 21.74 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -111.05 104.83 13.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -126.61 155.28 42.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.239 0.542 . . . . 0.0 111.171 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 9' ' ' GLY . 35.0 m -143.62 156.91 44.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.463 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -103.09 105.53 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.665 ' C ' HD23 ' A' ' 27' ' ' LEU . 4.1 tt -115.47 132.9 56.48 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.719 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -98.89 100.43 11.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.482 0.658 . . . . 0.0 112.243 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -179.15 101.73 0.2 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' ASN . 2.7 Cg_endo -58.03 -22.63 56.35 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.477 1.452 . . . . 0.0 113.498 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -147.56 134.31 20.03 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 34' ' ' ALA . 3.8 p -122.79 116.3 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 110.712 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.9 0.07 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.279 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -157.39 118.65 3.64 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.709 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 7.6 p-80 -151.41 136.26 17.26 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -130.6 121.44 25.65 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-O 120.941 0.401 . . . . 0.0 110.84 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.1 t90 -116.22 115.58 26.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.07 110.49 7.0 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.32 -111.19 0.18 Allowed 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' GLU . 38.5 t70 -54.42 165.9 0.5 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -66.19 40.2 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.05 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ASP . 54.0 mt-10 -135.93 138.87 28.87 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.401 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.1 144.9 99.19 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.102 1.201 . . . . 0.0 110.336 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.6 t -88.18 91.42 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.632 0.729 . . . . 0.0 111.952 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.6 mmp_? -148.42 -96.19 0.08 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 59.04 -124.69 1.31 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.941 177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.0 m -141.36 -144.76 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.367 0.53 . . . . 0.0 111.277 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.4 pt-20 -56.04 -39.22 71.66 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.819 -0.55 . . . . 0.0 110.702 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 41.4 p30 -64.89 4.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.649 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.72 132.66 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -177.23 138.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.129 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.45 143.14 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 111.299 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.98 149.01 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.64 152.93 27.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -133.25 -174.12 3.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.258 0.552 . . . . 0.0 111.587 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 60.56 23.36 13.08 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.588 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PRO . 53.4 t30 63.98 38.1 8.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.803 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.82 69.58 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.376 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.18 -28.15 69.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.043 0.921 . . . . 0.0 108.643 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -137.78 147.87 45.04 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.252 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -133.5 122.51 23.73 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.89 136.23 52.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.281 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 tp -117.74 117.27 28.88 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 tt -99.09 133.62 43.1 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.815 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -115.5 170.49 8.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.802 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -162.45 -176.28 4.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.947 0.403 . . . . 0.0 110.109 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.44 HD21 ' CB ' ' A' ' 49' ' ' ASN . 10.8 p30 41.07 55.9 3.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.18 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.434 HD12 ' CA ' ' A' ' 19' ' ' GLY . 98.0 mt -59.19 136.51 57.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.695 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -142.72 153.22 61.19 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.12 -37.65 93.97 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -55.35 -54.63 41.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.31 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -44.78 -44.18 9.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.9 t -45.4 114.75 0.8 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.179 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.7 t -150.73 -151.36 0.39 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.391 0.615 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -96.75 126.17 41.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.897 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 111.42 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.237 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.3 m -133.28 133.59 42.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.112 0.482 . . . . 0.0 111.017 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.412 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.6 t80 -139.43 127.81 22.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.246 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 79' ' ' LEU . 2.2 pt? -138.58 118.94 13.69 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.13 0.967 . . . . 0.0 112.101 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' SD ' ' A' ' 83' ' ' MET . . . -107.81 102.41 11.62 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 55.11 -150.62 18.9 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -51.48 12.07 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.56 118.85 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.815 0.734 . . . . 0.0 110.591 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.61 132.77 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.7 p -142.12 153.12 43.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.875 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 p -152.76 133.59 13.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 111.243 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.45 51.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.75 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 66.3 t80 -79.42 163.51 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.173 0.511 . . . . 0.0 111.742 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 52.6 tp -125.85 138.16 53.79 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.898 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.2 m -132.77 120.77 22.06 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.7 113.71 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.802 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -80.84 167.58 19.75 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.71 -142.12 4.17 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.91 101.46 0.2 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.4 mp -97.78 -5.0 35.85 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -88.19 132.61 34.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -154.01 9.17 0.37 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.416 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -106.05 103.32 12.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -150.91 166.38 30.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.21 -114.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.876 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.474 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 9.1 p80 -61.86 126.32 26.94 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.764 -179.789 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.61 -29.2 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.288 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -172.52 124.06 0.47 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 30.7 p-10 -136.73 106.94 6.37 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 93.9 m -150.7 115.7 5.3 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.955 -0.698 . . . . 0.0 112.085 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -63.32 134.07 28.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.09 -33.13 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.509 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -146.88 132.04 18.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.888 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.83 -167.77 42.63 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.89 169.14 13.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -133.77 145.06 49.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.487 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -55.12 146.74 17.67 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.64 130.18 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -125.82 129.15 48.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 148.24 17.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -77.61 162.38 27.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.507 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -52.08 134.44 32.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.873 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.25 21.71 66.84 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.411 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.47 -152.34 28.4 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 73.3 tt0 -136.29 158.25 44.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.678 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . . . -137.06 140.1 41.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.378 0.609 . . . . 0.0 111.65 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.73 131.82 33.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.485 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.0 107.8 15.85 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.928 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -97.86 105.11 17.21 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.022 0.439 . . . . 0.0 110.829 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.76 113.67 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.123 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -84.38 125.45 32.32 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 28' ' ' SER . 5.6 tt -125.21 132.3 53.02 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.384 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.5 m -89.06 98.47 11.78 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -178.31 106.46 0.21 Allowed Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' ASN . 3.6 Cg_exo -59.72 -32.24 95.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.462 1.441 . . . . 0.0 113.236 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 29' ' ' GLN . 15.0 pt-20 -110.51 -168.74 1.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 32' ' ' VAL . 4.2 p 160.15 111.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.39 -52.59 3.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.988 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.47 132.52 56.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.308 0.575 . . . . 0.0 111.884 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 1.3 p-80 -154.4 139.05 16.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.765 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -108.89 117.02 33.11 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.207 0.527 . . . . 0.0 111.007 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.59 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 12.2 m95 -111.38 119.87 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.914 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.1 mt -141.81 105.75 4.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.061 0.458 . . . . 0.0 110.872 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -109.99 0.15 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.0 p30 -56.94 165.75 1.18 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' OD1' ' OE1' ' A' ' 42' ' ' GLU . 14.9 p-10 -65.0 41.09 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' OE1' ' OD1' ' A' ' 41' ' ' ASP . 8.4 mp0 -136.31 139.74 30.68 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.0 144.68 88.86 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.191 1.26 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 t -87.78 85.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.474 0.654 . . . . 0.0 112.2 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 24.2 mmt180 -147.56 -91.91 0.08 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 47' ' ' SER . 2.7 p 59.02 -125.07 1.32 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.2 t -143.36 -142.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.261 0.553 . . . . 0.0 111.924 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -52.66 -46.49 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.903 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 22.3 t-20 -60.44 -1.66 0.39 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.804 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.73 133.63 0.07 Allowed 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -175.07 136.27 0.38 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.573 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.17 140.0 16.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.271 0.558 . . . . 0.0 109.787 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.13 146.87 18.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 51.9 p90 -136.28 -175.65 4.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 67.4 m-85 -157.68 167.72 29.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.433 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 57.23 36.64 27.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 30' ' ' PRO . 92.1 m-20 61.89 31.82 18.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.466 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.73 0.68 56.42 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 114.316 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.64 -20.7 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.206 1.003 . . . . 0.0 110.164 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -136.3 148.18 47.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.337 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -128.72 107.37 9.62 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.998 0.427 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.485 HD23 ' C ' ' A' ' 62' ' ' LEU . 8.3 tt -113.54 124.06 51.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.926 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.36 113.61 25.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.19 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.6 pp -96.81 141.56 29.88 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 3.7 mm? -118.05 168.65 10.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -157.84 176.86 12.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 39.49 52.29 2.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.068 0.461 . . . . 0.0 110.586 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 mt -59.49 147.48 36.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.216 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -139.27 151.03 66.42 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.64 -41.4 77.88 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.81 -53.38 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.462 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -47.66 -36.92 11.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -53.41 137.28 35.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.203 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.9 t -176.24 -150.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.401 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -90.58 142.31 27.88 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.901 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.92 129.02 76.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 m -135.37 132.18 37.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.315 0.579 . . . . 0.0 111.506 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 80' ' ' ALA . 2.4 t80 -126.27 115.9 20.42 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.4 tt -112.64 92.97 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -111.62 99.34 8.09 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 47.96 -161.05 0.46 Allowed Glycine 0 CA--C 1.539 1.55 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.34 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -45.7 -1.56 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.556 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.1 mpp? -114.47 126.78 55.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.712 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 84' ' ' VAL . 16.9 m -130.72 129.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.061 0.458 . . . . 0.0 110.486 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -123.45 143.46 50.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.304 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 m -152.9 129.44 10.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.838 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.1 150.41 44.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.283 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -78.66 166.84 22.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.959 0.885 . . . . 0.0 112.284 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 tp -126.94 135.32 50.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.687 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.7 m -136.93 123.74 21.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.09 0.472 . . . . 0.0 111.483 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.67 131.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -124.83 159.21 31.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.529 . . . . 0.0 111.884 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.03 99.35 0.18 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.27 123.92 6.24 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.933 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.93 128.92 55.05 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.61 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.843 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -156.48 -43.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.4 m170 -111.11 138.65 47.27 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.989 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -111.75 113.41 25.76 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 95.0 m-70 -98.0 94.95 7.15 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.024 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 100' ' ' HIS . 30.1 m80 53.17 112.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.129 -179.768 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.55 -30.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.304 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 6.7 tmtt? -158.16 115.14 2.88 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' OD1' ' CE ' ' A' ' 83' ' ' MET . 47.4 t30 -141.65 113.48 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 31.0 m -143.24 112.57 6.78 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' N ' ' SD ' ' A' ' 83' ' ' MET . 14.5 p -65.53 132.04 31.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.301 0.572 . . . . 0.0 111.3 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.53 -43.81 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -155.69 150.16 25.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.307 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.2 -145.18 8.91 Favored Glycine 0 C--N 1.321 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG12 ' A' ' 76' ' ' VAL . 34.9 mt -73.72 151.4 40.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.488 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -132.79 151.83 51.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.9 p-10 -50.75 142.35 11.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG11 ' HB1' ' A' ' 21' ' ' ALA . 83.3 t -133.54 131.89 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -128.49 127.32 42.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.982 0.42 . . . . 0.0 110.896 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.72 141.23 26.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.144 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.06 171.85 14.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.124 0.488 . . . . 0.0 109.772 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -45.84 139.52 4.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.77 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.37 25.63 68.69 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.41 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.92 -175.1 44.09 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -125.0 157.33 36.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -144.17 142.03 30.3 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.544 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.18 120.74 26.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.841 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -112.51 101.88 10.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -113.23 140.15 48.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 m -125.38 147.61 49.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.674 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -109.23 99.97 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -113.0 131.62 55.69 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.342 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 t -97.73 93.08 6.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.184 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 27' ' ' LEU . 6.2 tt0 -174.14 107.28 0.29 Allowed Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.02 -25.51 77.72 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 120.893 1.062 . . . . 0.0 112.859 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.19 139.72 20.56 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.603 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.9 p -123.63 118.46 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.026 0.441 . . . . 0.0 110.335 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.63 -0.06 40.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.883 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -161.44 111.17 1.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 9.5 p-80 -147.61 134.03 19.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.995 0.426 . . . . 0.0 111.452 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.9 m -129.91 125.74 36.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.006 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.6 t90 -123.79 105.74 9.91 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.963 0.411 . . . . 0.0 111.02 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.26 115.38 18.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.082 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.93 -111.77 0.13 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 59.1 t0 -57.02 163.9 1.83 Allowed 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -65.26 38.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 40' ' ' ASP . 23.7 mp0 -132.66 136.2 27.43 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.04 137.58 69.55 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 119.851 0.983 . . . . 0.0 109.688 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.8 p -88.66 86.17 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.041 0.924 . . . . 0.0 113.077 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.568 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.7 mmm180 -145.6 -92.34 0.1 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.5 p 62.7 -129.52 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.47 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.664 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.4 p -134.07 -150.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.451 0.643 . . . . 0.0 112.047 -177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.6 mm-40 -53.33 -43.66 67.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.811 -0.555 . . . . 0.0 110.451 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 27.7 t-20 -64.09 9.89 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.373 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 168.21 127.97 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -179.88 142.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.631 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.57 158.02 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.2 150.21 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.613 0.244 . . . . 0.0 110.842 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.4 m-85 -102.38 140.76 36.23 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.651 0.739 . . . . 0.0 112.691 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 62' ' ' LEU . 61.1 m-85 -136.89 146.14 45.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.702 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 53.27 38.05 26.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.945 0.402 . . . . 0.0 111.333 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.7 t30 62.52 41.77 9.36 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.24 2.26 87.09 Favored Glycine 0 N--CA 1.465 0.586 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.432 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.1 -15.59 62.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -146.97 156.58 43.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.888 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 51.9 m80 -144.37 135.75 25.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 55' ' ' PHE . 5.4 mp -126.85 138.57 53.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.032 0.444 . . . . 0.0 110.589 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.1 tp -121.78 116.8 25.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.876 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -101.31 133.71 45.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -114.9 169.4 9.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 54.1 tttp -152.37 167.74 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.915 0.325 . . . . 0.0 110.313 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 92.4 m-20 37.19 52.28 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 91' ' ' VAL . 94.7 mt -60.71 111.57 1.67 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -101.37 158.08 32.45 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.625 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -52.4 -30.8 44.99 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 N-CA-C 108.465 -1.398 . . . . 0.0 108.465 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -55.23 -61.33 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' SER . 90.9 m-20 -46.75 -42.2 16.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 72' ' ' ASP . 3.6 p -44.05 116.83 1.07 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.386 0.994 . . . . 0.0 110.221 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.7 t -155.19 -154.79 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.724 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.2 tpt85 -96.71 132.63 42.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.832 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 10' ' ' LEU . 2.3 t -111.98 120.96 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 m -135.58 130.13 34.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 55.7 t80 -118.93 113.18 20.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 79' ' ' LEU . 7.4 tt -110.44 85.82 2.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.141 0.496 . . . . 0.0 110.581 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -106.22 95.07 5.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.566 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 48.97 -159.29 0.86 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 45.4 t0 -45.24 -7.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.629 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 1.1 mtm -105.61 118.6 37.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.54 0.209 . . . . 0.0 111.102 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 m -131.81 134.61 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 p -141.3 154.24 45.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 t -154.82 136.01 13.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.953 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.04 51.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.204 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -78.4 164.78 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.445 0.641 . . . . 0.0 111.909 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -129.43 137.63 51.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.092 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -138.45 126.83 23.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.801 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 68' ' ' LEU . 11.6 t -138.97 125.61 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.197 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.69 164.19 24.8 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.979 0.419 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.25 -142.26 11.94 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -155.38 -175.38 26.36 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 94' ' ' GLY . 10.6 mp -112.47 125.86 54.69 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -97.42 117.75 32.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.893 0.377 . . . . 0.0 110.423 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.89 -3.93 17.2 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 11.57 25.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.094 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -82.44 7.15 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.465 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -95.07 -54.41 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -155.34 89.6 1.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.942 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.88 -40.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.104 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' NZ ' ' OG1' ' A' ' 5' ' ' THR . 25.3 tptp -165.58 124.26 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.503 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.8 p30 -138.16 110.71 7.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.431 ' OG1' ' NZ ' ' A' ' 3' ' ' LYS . 90.8 m -145.05 111.4 5.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.195 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HG2' ' A' ' 83' ' ' MET . 6.0 p -65.61 128.92 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.1 -46.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.0 ttm-85 -151.58 151.74 31.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.711 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.71 -142.29 9.11 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.33 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 mt -82.89 158.96 22.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.948 0.404 . . . . 0.0 111.224 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -133.19 154.65 50.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -58.55 149.13 26.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.907 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -135.21 132.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -124.24 126.01 45.37 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.067 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.64 148.3 24.09 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.2 mp -75.76 162.09 28.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.878 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -46.04 147.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.649 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.96 70.69 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.786 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.86 -174.64 36.54 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -120.51 157.73 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -145.36 143.87 30.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.123 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.43 118.31 22.89 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.385 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -113.53 101.48 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -124.24 157.21 35.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.222 0.534 . . . . 0.0 111.391 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.0 157.74 43.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.347 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.45 112.02 23.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.847 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.92 132.61 56.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -87.96 94.77 9.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.311 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 179.24 97.09 0.17 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.08 -20.61 70.34 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.818 1.678 . . . . 0.0 114.006 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -146.73 134.99 21.75 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.968 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 32' ' ' VAL . 2.5 m -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.46 0.648 . . . . 0.0 111.515 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.07 0.41 40.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.584 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.41 109.8 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.095 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.738 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -133.54 134.21 43.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.167 0.508 . . . . 0.0 110.692 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.97 118.39 22.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.507 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.4 t90 -123.53 111.5 16.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -132.02 115.91 16.41 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 111.513 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.425 HD23 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -99.63 -112.71 0.17 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 42' ' ' GLU . 35.7 m-20 -55.48 164.33 1.04 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.4 37.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.367 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 40' ' ' ASP . 13.9 pt-20 -127.75 139.29 34.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -54.26 133.17 54.48 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 N-CA-C 108.682 -1.314 . . . . 0.0 108.682 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.9 p -88.42 83.4 2.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.468 1.128 . . . . 0.0 112.538 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 45.8 mmm-85 -145.2 -89.15 0.1 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.664 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER 61.02 -128.92 0.85 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.498 177.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.3 p -135.87 -148.04 0.28 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' N ' ' OG ' ' A' ' 47' ' ' SER . 53.2 mp0 -54.54 -41.69 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.61 -0.682 . . . . 0.0 109.965 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 10.6 m120 -65.73 6.38 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.2 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 169.07 128.09 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 179.06 145.31 0.15 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.75 159.14 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 m -143.43 148.69 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.678 0.275 . . . . 0.0 110.498 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' CD2' ' CA ' ' A' ' 58' ' ' GLY . 6.0 m-85 -98.42 139.39 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.307 0.575 . . . . 0.0 111.29 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 62' ' ' LEU . 9.9 m-85 -127.7 147.16 50.38 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 41.29 40.13 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.44 41.84 0.95 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 82.71 -0.38 89.48 Favored Glycine 0 N--CA 1.468 0.809 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.154 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.1 tt -66.29 -18.96 65.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -145.68 93.34 2.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.678 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 58.5 m80 -83.13 134.6 34.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.864 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 55' ' ' PHE . 13.2 mt -114.92 132.18 56.63 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 HD21 HD23 ' A' ' 39' ' ' LEU . 12.9 tp -117.51 105.77 12.44 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -99.1 132.19 44.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.12 168.08 10.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.886 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' ASN . 62.8 tttp -150.56 163.79 37.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.176 0.444 . . . . 0.0 110.694 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 66.0 t30 38.18 55.26 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.915 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.0 mt -59.49 109.62 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.989 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 154.55 37.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.998 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.38 -38.23 82.34 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.486 1.457 . . . . 0.0 110.415 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -55.73 -56.01 25.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.82 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -47.43 -35.33 8.33 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 15.2 m -40.85 120.71 1.36 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.284 0.564 . . . . 0.0 111.352 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 73' ' ' SER . 1.2 m -171.03 -163.6 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.438 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -88.41 143.53 26.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.71 106.66 20.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.546 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 p -119.31 137.41 53.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.57 0.7 . . . . 0.0 111.974 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 29.9 t80 -126.27 117.63 23.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.863 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.3 93.2 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.317 0.58 . . . . 0.0 112.256 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.738 ' HB1' ' CE1' ' A' ' 35' ' ' HIS . . . -118.56 114.67 23.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 58.62 -175.95 2.43 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -57.35 29.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mpp? -129.39 132.71 47.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.76 0.254 . . . . 0.0 110.421 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.38 135.03 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.7 p -144.6 143.67 30.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.686 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 m -147.48 143.1 27.62 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.664 0.268 . . . . 0.0 110.901 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.51 147.94 47.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.944 0.402 . . . . 0.0 110.7 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.13 161.65 27.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.62 0.724 . . . . 0.0 112.322 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.46 131.24 53.77 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.794 -1.094 . . . . 0.0 108.734 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -128.4 116.82 20.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.616 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.81 118.92 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.871 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 -99.53 137.98 37.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.092 0.472 . . . . 0.0 111.192 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.41 -23.82 0.03 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.49 120.95 5.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.86 135.43 42.33 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -84.19 -10.42 57.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.935 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -90.27 6.59 42.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -80.17 129.65 34.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -125.61 118.13 25.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.984 0.421 . . . . 0.0 110.322 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.463 ' C ' ' N ' ' A' ' 102' ' ' HIS . 75.5 t60 -106.32 15.48 26.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.233 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 81.8 t60 47.2 15.47 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.502 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.463 ' N ' ' C ' ' A' ' 100' ' ' HIS . 51.2 t-80 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.414 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.64 -39.53 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.27 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.47 137.12 4.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.962 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.44 ' C ' ' SD ' ' A' ' 83' ' ' MET . 0.9 OUTLIER -143.39 108.83 5.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.471 ' CA ' ' SD ' ' A' ' 83' ' ' MET . 18.9 m -139.04 108.48 6.15 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.074 0.464 . . . . 0.0 110.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.605 ' N ' ' SD ' ' A' ' 83' ' ' MET . 12.3 p -74.68 127.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.632 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.11 -46.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.103 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 27.8 ttm180 -141.74 137.03 31.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.6 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.97 178.67 37.73 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.8 mt -76.34 153.9 35.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.741 0.305 . . . . 0.0 110.313 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -129.4 179.21 5.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -65.41 153.79 40.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.4 t -133.91 134.29 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.51 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -115.86 124.0 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.798 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.37 127.77 14.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.862 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.2 mp -72.19 162.15 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.96 136.46 22.85 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.03 66.87 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.35 -162.35 36.82 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.83 142.89 49.19 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -135.36 131.88 36.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.364 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -119.77 116.43 25.9 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.121 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -108.99 96.65 6.46 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.12 156.73 41.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.579 0.704 . . . . 0.0 111.769 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -140.2 147.48 40.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.947 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.4 120.96 44.09 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -134.13 179.08 6.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -121.25 104.54 9.81 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.759 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 179.46 95.06 0.18 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.606 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.82 -15.53 47.46 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.131 1.221 . . . . 0.0 110.498 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.5 133.22 16.87 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.601 HG21 ' ND1' ' A' ' 35' ' ' HIS . 1.4 m -102.68 169.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.86 0.838 . . . . 0.0 113.198 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 -40.34 5.42 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.13 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.44 127.32 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.601 ' ND1' HG21 ' A' ' 32' ' ' VAL . 32.9 p-80 -153.32 132.82 12.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -126.5 126.53 43.89 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.085 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 t90 -118.64 98.67 6.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.884 0.374 . . . . 0.0 111.046 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.88 114.51 17.98 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.42 -105.9 0.16 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 59.4 p30 -59.35 164.6 3.2 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -67.07 37.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.712 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 70.0 mt-10 -134.73 141.45 38.7 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.43 134.53 64.44 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 CA-C-N 120.079 1.064 . . . . 0.0 109.81 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.0 p -80.01 84.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.837 0.827 . . . . 0.0 112.454 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.639 ' O ' ' O ' ' A' ' 50' ' ' ALA . 56.7 ttp180 -148.3 -87.21 0.09 Allowed 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 50' ' ' ALA . 1.8 p 60.47 -135.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.923 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 12.3 t -135.42 -144.42 0.21 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.446 0.641 . . . . 0.0 112.624 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 mm-40 -45.48 -51.87 11.04 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.709 -0.619 . . . . 0.0 110.625 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 52.6 p-10 -61.86 4.8 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.784 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 46' ' ' THR . . . 170.1 130.88 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.251 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -177.47 137.11 0.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.72 141.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 CA-C-O 121.577 0.703 . . . . 0.0 110.987 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 m -131.01 136.19 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -123.66 117.1 24.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.398 -178.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CB ' ' OE1' ' A' ' 56' ' ' GLU . 92.3 m-85 -113.21 170.32 8.3 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.381 0.61 . . . . 0.0 112.594 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' OE1' ' CB ' ' A' ' 55' ' ' PHE . 54.7 mp0 63.35 37.06 11.16 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.287 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 61.35 47.56 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 54' ' ' PHE . . . 77.53 15.0 81.87 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.403 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tp -90.19 -14.58 33.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -138.61 105.58 5.43 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.198 0.453 . . . . 0.0 112.084 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 2.4 m80 -78.95 108.76 12.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.548 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.26 128.68 52.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.79 0.329 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -119.2 117.09 27.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.191 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.87 138.01 34.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.561 0.696 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.25 117.07 8.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.333 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -104.58 -169.05 1.56 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.984 0.811 . . . . 0.0 112.593 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.445 ' ND2' ' HE ' ' A' ' 69' ' ' ARG . 7.4 t-20 38.36 53.95 1.78 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.188 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 2.4 mm? -60.66 106.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.681 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HE ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -103.93 158.71 31.32 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.583 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.86 -31.44 88.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.14 -65.74 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.938 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.54 -39.29 16.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -46.49 127.02 8.86 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.561 0.619 . . . . 0.0 111.301 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 12.5 p -171.31 -149.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.629 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 41.1 ttm180 -96.92 139.48 32.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.709 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.02 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.269 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.2 m -130.68 126.95 37.84 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 63.5 t80 -121.76 116.85 25.25 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tp -111.6 87.75 2.63 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -99.96 92.59 5.34 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 46.98 -163.88 0.15 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -37.32 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.058 0.456 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 9.0 mtm -87.47 115.22 24.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' VAL . 4.0 m -123.51 128.97 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.899 0.381 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.87 131.33 44.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.736 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.6 p -154.35 148.9 26.3 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.598 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.68 37.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.94 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -85.67 174.18 9.58 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.326 0.584 . . . . 0.0 111.011 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 90' ' ' THR . 5.5 tt -138.91 146.86 41.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.894 ' N ' HD23 ' A' ' 89' ' ' LEU . 95.3 m -141.9 132.3 25.15 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.151 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -130.52 116.42 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.121 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -112.72 149.55 32.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.589 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.63 -136.36 8.64 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.72 119.34 5.06 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.9 tp -121.25 120.65 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.72 0.295 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -144.75 35.93 1.16 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.65 55.96 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.2 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.432 ' N ' ' ND1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -155.82 159.99 39.86 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.099 179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -112.24 77.72 1.07 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -81.36 132.16 35.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.114 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -56.19 153.5 9.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.7 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.807 -179.668 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.779 0.323 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.56 -38.4 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.121 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -166.7 126.98 1.59 Allowed 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.303 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 54.4 t30 -143.86 110.36 5.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -146.52 111.66 5.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 120.752 -0.379 . . . . 0.0 112.009 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.8 p -66.87 133.28 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.278 0.561 . . . . 0.0 111.683 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 71.8 t -95.69 -41.15 11.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.891 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -138.85 131.26 28.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.326 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.53 176.24 28.63 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' H ' ' HB ' ' A' ' 85' ' ' THR . 89.4 mt -71.99 145.05 48.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -130.23 151.42 50.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.291 0.567 . . . . 0.0 111.103 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -36.68 153.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.812 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 21' ' ' ALA . 69.9 t -136.03 134.97 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.396 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -118.33 124.6 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.286 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.09 141.37 18.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.61 167.69 20.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 92' ' ' ARG . 12.7 pt-20 -35.18 148.13 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.464 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 38.1 32.02 0.12 Allowed Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.29 -163.8 36.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' OE2' HD11 ' A' ' 64' ' ' LEU . 40.6 tp10 -127.42 135.82 50.97 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -141.21 136.55 31.85 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -133.94 136.3 44.12 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 111.636 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 76' ' ' VAL . 60.7 m-85 -112.79 101.37 9.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.716 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 50.6 mp0 -107.79 128.74 54.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.526 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -119.26 130.35 55.39 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' OE1' ' N ' ' A' ' 27' ' ' LEU . 2.0 tp-100 -111.85 104.45 12.76 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.827 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -122.2 174.54 6.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.051 0.453 . . . . 0.0 111.627 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.2 t -119.65 100.57 7.34 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.964 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -172.31 82.46 0.45 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -70.36 31.97 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.704 1.603 . . . . 0.0 111.798 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' GLN . 3.3 pm0 -149.24 167.49 25.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 32' ' ' VAL . 2.0 m -137.66 123.2 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.081 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.39 -37.21 5.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.671 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.51 122.75 0.89 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.165 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.48 130.53 20.64 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.658 0.266 . . . . 0.0 111.156 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.4 m -129.58 127.77 41.37 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.161 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.8 t90 -122.49 108.5 13.24 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.7 mt -132.52 109.54 9.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -105.86 0.08 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 66.1 t0 -59.49 164.16 3.63 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 173.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 41.0 p-10 -67.61 43.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.781 -0.768 . . . . 0.0 112.057 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' ASP . 28.0 mt-10 -138.39 134.27 17.47 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 119.209 -0.424 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.53 137.63 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.269 1.313 . . . . 0.0 110.355 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.19 81.4 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.748 ' O ' ' N ' ' A' ' 47' ' ' SER . 94.7 mtt-85 -151.29 -64.74 0.19 Allowed 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 23.34 -52.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.748 ' N ' ' O ' ' A' ' 45' ' ' ARG . 9.7 p -172.4 167.14 5.72 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.673 0.67 . . . . 0.0 110.921 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -44.8 -34.1 2.17 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 109.292 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASN . 38.3 t30 -62.12 6.18 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.07 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 48' ' ' GLU . . . 176.16 124.05 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.553 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -178.33 137.6 0.17 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.849 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.15 152.7 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.253 0.549 . . . . 0.0 110.798 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.71 151.17 15.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.896 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.7 m-85 -104.94 142.64 34.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -136.52 144.15 44.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.504 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.07 38.52 29.19 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.062 0.458 . . . . 0.0 110.337 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 61.94 41.33 11.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.298 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.483 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 80.5 -2.81 76.52 Favored Glycine 0 N--CA 1.466 0.653 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.49 -19.69 63.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -146.54 93.9 2.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.682 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.644 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.4 m80 -81.67 125.76 30.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.883 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -111.15 130.9 55.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.164 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 65' ' ' LEU . 15.4 tp -122.54 118.06 27.36 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.505 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.609 HD11 ' OE2' ' A' ' 20' ' ' GLU . 14.7 tp -101.95 120.74 40.88 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD21 HD11 ' A' ' 63' ' ' LEU . 47.0 mt -122.59 108.84 13.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.171 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 ttpp -100.5 -166.83 1.36 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.099 0.476 . . . . 0.0 111.477 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.741 HD21 HH21 ' A' ' 69' ' ' ARG . 59.4 t30 36.07 48.62 0.55 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.428 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.35 108.49 2.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.741 HH21 HD21 ' A' ' 67' ' ' ASN . 4.5 mtt180 -107.51 177.96 1.19 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.47 -23.86 43.24 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.617 1.545 . . . . 0.0 111.035 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.36 -64.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.309 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 69' ' ' ARG . 2.9 p30 -46.93 -39.04 11.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 9.2 t -34.1 112.9 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.656 0.662 . . . . 0.0 112.713 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 24.4 p -164.61 -173.42 3.02 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 111.753 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' ARG . 3.4 mmt-85 -87.98 151.97 22.39 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 23' ' ' PHE . 21.5 t -116.32 118.31 58.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.6 m -118.46 123.58 45.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.324 0.583 . . . . 0.0 111.733 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 54.8 t80 -122.41 114.38 20.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.4 tt -110.88 90.3 3.29 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.33 91.36 4.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.975 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.29 -158.74 4.18 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -49.42 5.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.588 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -117.82 126.84 53.17 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.239 -0.288 . . . . 0.0 111.065 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.78 133.01 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.93 0.395 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 2.0 p -130.11 130.81 45.29 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.968 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 83.0 p -158.77 153.7 25.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 112.245 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.83 167.07 31.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.574 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -81.71 167.96 18.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.001 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 27.6 tp -123.8 134.44 53.63 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.9 m -122.59 113.63 19.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.48 119.86 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.564 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 24.9 mmt180 -98.47 131.42 44.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.299 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.87 -175.69 50.05 Favored Glycine 0 N--CA 1.465 0.623 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.07 -69.33 0.06 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.4 mt -114.08 131.6 56.33 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -79.88 -91.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -155.56 -46.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.803 0.335 . . . . 0.0 111.554 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 98' ' ' HIS . 42.7 p-80 -137.16 59.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.952 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -91.42 -10.45 40.98 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.434 ' CG ' ' N ' ' A' ' 101' ' ' HIS . 82.3 t60 -145.44 159.92 42.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.463 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.485 ' N ' ' ND1' ' A' ' 101' ' ' HIS . 6.9 p-80 -155.51 159.35 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.079 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.45 ' C ' ' ND1' ' A' ' 102' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.222 -0.346 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.72 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.84 -31.29 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.458 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -165.0 127.02 2.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.36 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -146.35 109.43 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 m -138.32 114.46 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.092 0.473 . . . . 0.0 110.613 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 83' ' ' MET . 10.3 p -65.94 132.44 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.714 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.03 -40.19 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -138.6 135.19 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.292 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.46 -167.44 36.79 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.72 166.88 22.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -140.83 165.78 26.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.63 143.36 50.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.34 134.36 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.39 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.4 mp0 -127.77 131.97 49.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.11 144.4 17.4 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -77.78 162.23 27.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.467 0.651 . . . . 0.0 111.471 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -41.98 150.84 0.11 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.578 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.85 22.69 9.34 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.23 -175.7 48.91 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -121.8 145.14 48.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.75 138.04 38.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.974 0.416 . . . . 0.0 110.54 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -137.93 133.78 34.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.97 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.73 107.82 17.04 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.373 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -95.15 105.4 17.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.34 162.03 14.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.201 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -131.08 120.66 23.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -116.01 133.03 56.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 m -89.91 98.77 11.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 169.0 113.11 0.04 OUTLIER Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.28 -17.17 58.85 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 120.905 1.07 . . . . 0.0 112.415 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -151.25 140.89 21.72 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.531 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 32' ' ' VAL . 8.6 p -117.15 111.17 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.577 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.17 1.55 22.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.085 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.75 101.89 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -154.62 154.04 32.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.715 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.4 m -132.36 125.25 30.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.966 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.56 ' CD1' HG21 ' A' ' 44' ' ' VAL . 2.0 t90 -117.66 116.33 26.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 110.565 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.12 110.46 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.455 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.21 -104.94 0.14 Allowed 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' GLU . 53.4 t0 -63.97 166.93 6.81 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 34.7 t70 -64.31 33.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ASP . 79.9 mt-10 -125.2 135.52 26.96 Favored Pre-proline 0 N--CA 1.475 0.797 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.66 141.16 95.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.636 1.557 . . . . 0.0 110.027 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.3 t -85.18 87.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.862 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' O ' ' O ' ' A' ' 50' ' ' ALA . 21.6 mmm180 -146.57 -89.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.1 p 59.06 -129.16 1.23 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.704 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.602 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.3 t -128.36 -150.46 0.44 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.06 -37.5 87.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -62.0 -5.17 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -178.56 129.87 0.12 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 45' ' ' ARG . 84.1 tt0 178.44 148.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.54 142.63 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.937 0.398 . . . . 0.0 110.156 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.5 148.88 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 48.6 p90 -138.01 -175.22 4.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.522 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 76.1 m-85 -158.19 166.97 31.09 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.873 0.368 . . . . 0.0 111.458 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 54.71 35.56 24.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.188 0.518 . . . . 0.0 111.107 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.3 38.87 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.939 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.7 -2.3 82.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.204 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.67 -21.17 62.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.941 0.871 . . . . 0.0 109.864 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -138.83 150.38 45.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.591 ' C ' HD12 ' A' ' 62' ' ' LEU . 48.4 m80 -134.88 119.59 18.26 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.338 0.589 . . . . 0.0 110.443 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.1 mp -119.38 119.24 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.078 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.2 tp -109.95 117.62 34.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 63' ' ' LEU . 10.7 mp -106.99 127.92 53.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.104 0.478 . . . . 0.0 111.434 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.9 mt -129.56 118.01 21.35 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -99.65 -166.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.06 0.391 . . . . 0.0 111.68 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 36.51 45.04 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.555 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.13 106.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.6 mtt180 -102.42 -179.52 0.8 Allowed Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 6.1 Cg_exo -66.32 -34.77 34.13 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.162 1.241 . . . . 0.0 110.234 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.23 -56.62 19.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.432 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -48.97 -38.0 21.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 p -46.68 121.37 3.49 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.164 0.893 . . . . 0.0 110.552 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 9.1 t -161.78 -138.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.423 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 75.9 ttt180 -111.62 135.96 51.49 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.209 0.528 . . . . 0.0 112.284 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.12 108.98 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.069 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -125.42 128.87 48.78 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.957 0.408 . . . . 0.0 111.107 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 68.5 t80 -134.09 121.25 21.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.635 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -120.33 101.47 7.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.582 0.706 . . . . 0.0 112.002 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 79' ' ' LEU . . . -107.47 94.03 4.87 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.94 -159.73 22.25 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -53.09 10.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.598 ' H ' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -116.72 120.31 38.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.095 0.407 . . . . 0.0 111.21 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.534 HG12 HD23 ' A' ' 79' ' ' LEU . 23.1 m -123.24 129.0 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.059 0.456 . . . . 0.0 110.808 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.66 131.27 51.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -147.33 139.87 24.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.04 157.63 43.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.536 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -78.39 159.96 28.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.3 tp -130.45 139.42 50.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.625 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.4 p -141.53 128.59 20.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.635 0.255 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.95 122.58 26.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.979 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -92.16 128.71 38.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.747 0.308 . . . . 0.0 110.439 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.63 14.65 0.15 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.57 53.18 4.48 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.1 tp -106.9 -38.6 6.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -91.31 145.83 24.32 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.839 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -88.93 101.93 14.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -101.28 49.83 0.87 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.182 0.515 . . . . 0.0 110.624 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -116.24 15.76 15.89 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -75.79 -46.38 30.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.783 0.325 . . . . 0.0 110.496 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.07 157.44 46.33 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.617 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.84 1.72 0.01 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.876 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -163.64 124.99 2.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.346 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 23.7 p30 -129.62 127.55 40.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.5 m -147.83 108.78 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' ' SD ' ' A' ' 83' ' ' MET . 6.0 p -68.95 129.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.071 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.27 -42.08 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -142.76 131.97 23.31 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.033 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.67 -178.33 36.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.8 mt -69.46 163.91 24.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.353 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -137.48 168.17 20.17 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -61.97 146.39 50.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.538 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.8 t -131.14 131.09 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -124.75 132.34 53.37 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.63 145.96 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.683 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.86 158.29 32.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.074 0.464 . . . . 0.0 110.933 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -48.68 133.33 17.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.394 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.93 18.59 78.62 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.33 -159.32 35.46 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -135.88 148.9 48.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -137.03 136.31 38.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.051 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.45 130.35 38.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.311 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.47 104.52 12.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -103.76 116.83 33.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.952 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 26' ' ' GLN . 1.9 t -126.59 156.22 41.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.045 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 85.7 mt-30 -135.37 141.59 45.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD11 ' NE2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -143.61 172.67 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.305 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -112.51 104.71 12.82 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.484 ' NE2' HD11 ' A' ' 27' ' ' LEU . 6.7 pt20 172.82 109.53 0.06 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.91 -15.14 47.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 CA-C-N 120.028 1.046 . . . . 0.0 113.38 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -148.9 135.25 19.38 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.149 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 ' ND1' ' A' ' 35' ' ' HIS . 7.5 p -73.68 149.95 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.774 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.23 -35.8 5.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 114.277 -1.328 . . . . 0.0 108.953 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.94 121.45 1.05 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.496 ' ND1' HG23 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.47 130.91 44.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.096 0.474 . . . . 0.0 111.232 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.7 m -127.92 113.05 15.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.58 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -118.72 119.52 34.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 111.205 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.8 mt -144.8 112.55 6.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.714 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -98.78 -110.63 0.17 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 42' ' ' GLU . 37.8 t70 -54.46 164.22 0.75 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -65.54 32.79 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.72 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 40' ' ' ASP . 65.2 mt-10 -130.4 138.87 34.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.41 134.19 56.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 63' ' ' LEU . 7.3 p -86.33 86.74 2.53 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-O 121.927 0.87 . . . . 0.0 112.024 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.4 mtm-85 -150.99 -88.09 0.07 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.6 p 55.59 -120.69 1.59 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.592 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.9 t -134.78 -146.42 0.25 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.392 0.542 . . . . 0.0 111.715 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 50' ' ' ALA . 20.4 tp10 -61.73 -40.0 93.54 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 29.5 m120 -62.94 4.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.626 0.251 . . . . 0.0 111.529 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.61 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.72 130.93 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 178.46 145.83 0.14 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t -82.03 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.097 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 62' ' ' LEU . 3.6 m -130.47 134.89 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.85 155.04 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.109 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -134.53 160.96 36.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 77.82 28.99 0.52 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.466 0.65 . . . . 0.0 109.658 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.85 31.49 16.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.247 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.97 -9.11 61.51 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.388 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.31 -29.74 67.84 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.751 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -128.73 93.62 3.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.888 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.528 ' C ' HD12 ' A' ' 62' ' ' LEU . 28.5 m80 -86.39 117.7 25.35 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.599 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.0 mp -114.23 151.53 32.67 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.673 HD11 HG21 ' A' ' 44' ' ' VAL . 1.1 tt -141.48 115.61 9.33 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 63' ' ' LEU . 8.5 tp -108.18 128.16 54.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.7 mt -127.9 110.74 12.85 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.562 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -104.77 -161.04 0.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.276 0.489 . . . . 0.0 111.279 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 43.68 46.01 6.09 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.06 146.06 39.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.396 0.617 . . . . 0.0 111.699 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -144.53 155.96 56.82 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.217 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.61 -38.97 76.74 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 108.478 -1.393 . . . . 0.0 108.478 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.74 -53.12 52.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.279 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 53.0 t0 -46.06 -40.81 11.26 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 74.7 m -42.62 108.26 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.83 0.741 . . . . 0.0 110.57 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 56.6 m -155.01 -166.85 2.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.544 0.688 . . . . 0.0 111.726 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 76' ' ' VAL . 19.1 tpp85 -82.42 125.32 30.93 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.209 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 88.5 t -110.99 111.27 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.7 m -129.3 135.79 49.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.471 0.653 . . . . 0.0 111.678 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 26.9 t80 -124.99 116.76 22.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.89 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.69 92.59 4.0 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -109.07 98.69 8.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.68 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 57.09 -163.64 6.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.06 4.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.617 ' H ' ' C ' ' A' ' 81' ' ' GLY . 25.1 mtm -109.06 119.41 39.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.805 -0.18 . . . . 0.0 110.627 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.5 128.01 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.62 0.724 . . . . 0.0 110.596 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 p -129.03 125.89 38.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.3 m -142.52 140.2 31.72 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.23 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.0 155.67 44.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.01 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -80.0 164.76 23.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.737 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.1 tp -126.86 138.77 53.37 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 p -139.34 125.63 20.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.002 0.43 . . . . 0.0 110.993 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -135.11 120.75 30.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -83.96 174.07 10.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 110.587 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.52 -168.72 45.1 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.07 -154.69 7.42 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.3 tp -142.9 92.56 2.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.93 134.97 33.85 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.451 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -124.62 7.75 8.24 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -117.14 138.04 51.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.702 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -89.84 175.03 7.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -122.92 121.12 35.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 83.6 t60 43.03 26.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.045 0.45 . . . . 0.0 110.654 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.46 ' OXT' ' O ' ' A' ' 101' ' ' HIS . 88.0 m-70 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 117.889 -1.053 . . . . 0.0 111.35 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.75 -38.53 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.741 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -169.24 139.07 2.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.97 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p-10 -139.96 111.37 7.16 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -160.39 107.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 15.0 p -57.86 125.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.82 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.25 -29.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -153.76 124.08 7.02 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.415 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.81 49.72 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.0 162.65 27.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.714 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -134.89 161.76 34.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -57.06 141.3 46.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -135.44 134.33 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -129.05 137.99 51.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 129.2 18.56 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.224 0.535 . . . . 0.0 110.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 17' ' ' GLU . 1.8 pp -65.85 159.72 24.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.093 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 16' ' ' LEU . 14.9 tm-20 -41.57 129.38 3.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.241 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.03 34.49 61.74 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.041 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.14 -163.68 21.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.9 pm0 -130.64 177.07 7.66 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -130.57 132.45 45.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.709 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.839 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -116.54 103.11 10.08 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.335 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -107.2 101.85 11.21 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 110.688 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -100.99 115.92 31.62 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.408 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.16 130.07 51.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.646 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -109.48 125.42 52.45 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.913 HD23 ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.32 147.74 52.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 -178.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.4 m -96.45 90.0 5.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -174.71 97.81 0.28 Allowed Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.55 -21.83 52.16 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.443 1.428 . . . . 0.0 112.75 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -149.86 134.44 17.54 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.8 p -128.26 123.87 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.376 0.608 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.47 0.78 28.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.617 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -158.99 116.14 2.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.245 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -153.81 129.36 9.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.9 p -135.01 132.09 37.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.073 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.6 t90 -122.53 114.39 20.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.968 0.414 . . . . 0.0 110.078 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.17 115.7 11.98 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.891 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -97.59 -109.05 0.17 Allowed 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -56.4 163.15 1.81 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 88.0 m-20 -66.4 38.85 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.956 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 40' ' ' ASP . 27.2 mt-10 -133.18 139.32 33.86 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.49 132.64 41.04 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -87.04 82.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 122.371 1.081 . . . . 0.0 113.326 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' O ' ' O ' ' A' ' 50' ' ' ALA . 95.8 mtm-85 -147.62 -84.66 0.11 Allowed 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.8 p 59.12 -129.74 1.18 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.588 ' O ' ' O ' ' A' ' 50' ' ' ALA . 8.1 t -135.88 -144.87 0.21 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.1 mm-40 -54.54 -42.72 71.26 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.903 -0.498 . . . . 0.0 110.592 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 50.4 p30 -63.7 3.83 0.32 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.696 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 167.88 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.853 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 177.75 146.73 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.858 0.299 . . . . 0.0 110.532 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.6 160.82 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.8 m -139.04 151.37 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.064 0.459 . . . . 0.0 110.72 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 5.8 m-85 -109.71 146.4 34.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -141.31 148.23 39.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.985 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 49.85 36.25 10.94 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.802 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 62.77 39.17 11.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.01 2.89 74.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.667 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.08 -26.9 68.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -139.36 150.02 44.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.383 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.532 ' C ' HD12 ' A' ' 62' ' ' LEU . 62.8 m80 -136.56 122.56 20.19 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.8 mp -116.49 127.13 54.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.636 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 63' ' ' LEU . 6.4 tt -112.16 113.69 26.08 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 63' ' ' LEU . 44.4 tp -106.46 131.1 54.03 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.048 0.452 . . . . 0.0 112.089 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CB ' HD21 ' A' ' 68' ' ' LEU . 83.4 mt -109.19 173.02 6.51 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -150.11 164.05 36.59 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.647 0.26 . . . . 0.0 110.638 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 36.48 52.89 0.99 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.895 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.413 HD21 ' CB ' ' A' ' 65' ' ' LEU . 87.3 mt -61.96 111.6 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -93.55 154.83 41.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -48.54 -34.82 27.36 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 108.052 -1.557 . . . . 0.0 108.052 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -55.76 -56.89 15.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.043 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.96 -41.93 26.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 t -47.96 126.38 10.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.243 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.52 -153.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.226 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -94.34 140.73 29.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.8 t -120.28 126.61 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.7 m -131.61 131.62 43.38 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.537 . . . . 0.0 111.99 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 50.5 t80 -127.76 117.83 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 tp -122.33 98.47 5.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -124.61 125.8 44.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 45.43 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -52.02 14.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 81' ' ' GLY . 16.2 ptp -123.04 130.94 53.44 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.922 0.783 . . . . 0.0 110.908 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.91 123.52 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.05 128.2 48.14 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.362 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -144.4 138.54 27.83 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.8 0.333 . . . . 0.0 111.537 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.33 152.82 44.73 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.909 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -81.56 166.68 20.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 90' ' ' THR . 2.1 tt -131.6 140.13 49.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.792 ' N ' HD23 ' A' ' 89' ' ' LEU . 83.2 m -133.71 123.11 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 89' ' ' LEU . 40.8 t -134.12 124.46 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.724 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.34 159.45 31.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.026 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.81 -152.84 8.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.96 101.8 2.62 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.6 mt -100.28 -31.0 11.57 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.795 -0.238 . . . . 0.0 110.457 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -90.89 116.27 28.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -79.43 153.56 29.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -113.53 148.24 36.45 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.947 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -149.27 166.47 28.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.412 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' ND1' ' A' ' 101' ' ' HIS . 54.0 t-80 -135.56 108.03 7.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.434 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.514 ' ND1' ' CE1' ' A' ' 100' ' ' HIS . 77.5 m80 42.27 85.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.154 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 t60 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.953 179.613 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 -37.7 0.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.674 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -162.87 123.05 2.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.767 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 14.4 p-10 -132.64 119.41 20.4 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.539 ' N ' ' SD ' ' A' ' 83' ' ' MET . 99.9 m -158.74 107.54 1.93 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.664 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.1 t -62.23 127.84 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.39 -42.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -146.16 131.17 18.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.141 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.75 -177.13 39.74 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 85' ' ' THR . 17.4 mt -67.82 162.24 24.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.5 pm0 -140.71 168.63 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.995 0.426 . . . . 0.0 110.236 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 47.0 p30 -59.26 143.72 48.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.056 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -128.23 129.28 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.33 124.29 43.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.399 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.18 139.98 20.84 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 111.636 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 17' ' ' GLU . 55.0 tp -73.02 158.96 34.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.918 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' N ' ' HG ' ' A' ' 16' ' ' LEU . 76.9 tt0 -46.42 146.5 1.42 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.19 20.0 57.8 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.41 177.23 39.14 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -111.81 154.59 24.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -141.59 142.57 33.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.33 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 mp -135.56 129.73 33.43 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.563 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -109.53 105.2 14.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -101.03 111.1 23.21 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.437 0.637 . . . . 0.0 111.04 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -121.91 129.44 52.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.888 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.04 153.62 29.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -155.96 172.01 19.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.315 0.579 . . . . 0.0 111.165 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.6 t -117.83 89.47 3.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.791 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.4 tt0 -167.99 77.17 0.88 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.3 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.98 42.02 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.537 2.158 . . . . 0.0 111.283 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 32' ' ' VAL . 14.9 tm-20 -150.13 153.14 35.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 32' ' ' VAL . 2.4 m -133.63 117.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.39 -38.69 5.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.328 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.51 120.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -136.28 130.63 33.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.3 m -124.26 122.28 37.33 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CG ' HG11 ' A' ' 44' ' ' VAL . 3.0 t90 -123.45 125.3 44.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -158.79 121.92 3.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.064 0.935 . . . . 0.0 111.406 177.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -92.89 -100.58 0.13 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 42' ' ' GLU . 53.3 t0 -54.39 165.72 0.51 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.9 43.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.973 0.416 . . . . 0.0 111.55 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' ASP . 37.7 mt-10 -145.02 140.92 16.65 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.04 142.76 64.54 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 120.762 0.975 . . . . 0.0 109.892 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -87.75 86.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.923 0.868 . . . . 0.0 111.288 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.4 ttt85 -145.74 -87.24 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 56.69 -125.95 1.9 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.241 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.692 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t -140.27 -142.83 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 112.162 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.9 tt0 -53.72 -46.58 70.86 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.56 -0.713 . . . . 0.0 111.346 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 83.5 m-20 -60.85 3.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.692 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 171.68 133.08 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -177.95 140.0 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.465 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -91.92 147.95 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 110.007 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.28 147.59 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 12.6 m-85 -103.31 144.43 31.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.32 146.31 38.34 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.262 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.35 32.28 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.8 0.333 . . . . 0.0 110.688 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 64.08 38.93 8.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.774 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 86.54 -4.42 86.18 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.354 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.49 -20.4 66.33 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -146.31 89.25 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.169 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 54' ' ' PHE . 58.5 m80 -81.29 130.56 35.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.654 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 61' ' ' HIS . 11.0 mp -112.89 124.55 52.86 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.8 tp -112.17 106.61 15.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.71 153.04 26.77 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 122.407 1.099 . . . . 0.0 112.536 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.9 mt -140.56 163.42 32.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.605 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -156.95 175.84 13.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.078 0.399 . . . . 0.0 110.278 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 36.3 49.21 0.64 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 21' ' ' ALA . 96.7 mt -61.47 106.93 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -98.58 156.06 36.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.001 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.42 -36.05 77.86 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.289 1.326 . . . . 0.0 109.983 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -53.99 -52.65 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.801 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' SER . 54.1 t0 -44.59 -41.59 6.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.811 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' ASP . 39.1 m -38.75 111.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.258 0.481 . . . . 0.0 110.76 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.1 p -159.66 -173.74 4.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.5 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.57 137.24 35.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.35 116.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 m -128.6 130.59 47.54 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.902 0.382 . . . . 0.0 111.932 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -135.62 123.94 23.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.0 tt -113.52 95.44 5.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.48 92.48 4.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.191 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.84 -161.76 1.26 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -45.39 -12.08 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.607 0.241 . . . . 0.0 111.386 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.606 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 33.6 mtm -99.42 123.86 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.066 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 84' ' ' VAL . 4.3 m -130.3 131.18 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 10' ' ' LEU . 1.2 p -124.44 138.35 54.36 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -154.57 136.37 14.47 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.897 0.38 . . . . 0.0 111.379 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.09 159.88 43.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -82.71 167.41 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.646 0.736 . . . . 0.0 112.601 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.62 138.7 52.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.863 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -139.33 126.45 21.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.921 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.31 125.45 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -93.44 131.35 38.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.875 0.369 . . . . 0.0 111.752 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.95 0.8 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.87 -174.71 47.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' N ' ' A' ' 95' ' ' LEU . 1.1 mm? -108.2 124.29 50.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -79.91 117.85 21.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.937 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.41 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 84.0 t60 -158.22 -3.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.427 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -139.7 5.5 2.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.798 0.332 . . . . 0.0 110.76 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -122.8 47.41 1.96 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -83.98 -119.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.846 0.355 . . . . 0.0 110.804 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.8 -46.91 80.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.941 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.58 -39.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.855 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.27 123.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.201 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.34 111.29 8.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.1 m -137.29 112.22 8.96 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.8 p -60.53 122.34 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.378 0.609 . . . . 0.0 111.083 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.38 -40.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.702 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -151.7 131.84 13.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.986 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.91 -177.03 35.09 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.09 157.47 37.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.92 177.27 7.99 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p-10 -62.13 142.01 57.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 111.187 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG11 ' HB1' ' A' ' 21' ' ' ALA . 53.4 t -135.23 135.36 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.346 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.96 135.42 37.67 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.901 0.381 . . . . 0.0 110.931 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.09 150.62 25.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -78.1 160.6 27.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.113 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' C ' ' N ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -41.93 161.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.792 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.18 20.5 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 17' ' ' GLU . . . -87.38 -166.25 42.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -132.96 148.35 52.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.372 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB1' HG11 ' A' ' 13' ' ' VAL . . . -135.13 134.62 40.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.388 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.88 127.2 38.05 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.88 105.23 13.97 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.23 111.45 23.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 m -122.12 147.4 46.18 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.978 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -118.17 129.83 55.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.254 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 ' CE ' ' A' ' 83' ' ' MET . 31.0 mt -117.41 140.25 49.84 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.013 0.435 . . . . 0.0 111.634 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -95.86 88.94 5.09 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.548 ' C ' ' H ' ' A' ' 31' ' ' GLU . 6.8 tt0 -177.26 93.34 0.24 Allowed Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.54 18.29 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.608 1.539 . . . . 0.0 111.541 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.7 tt0 -135.96 162.14 33.7 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 32' ' ' VAL . 5.9 p 156.74 111.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.892 0.745 . . . . 0.0 110.331 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.13 -44.04 5.09 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.4 141.97 50.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.279 0.562 . . . . 0.0 110.849 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.22 165.51 36.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.5 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 m -121.09 104.57 9.88 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.891 0.376 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 21.4 m95 -109.69 91.83 3.8 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -128.1 123.02 33.48 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -103.28 -105.98 0.28 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 178.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 42' ' ' GLU . 49.2 p-10 -61.41 165.88 4.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -65.74 34.29 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 40' ' ' ASP . 22.7 mt-10 -130.16 135.43 27.44 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.1 137.6 70.03 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.73 0.954 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.6 p -91.55 87.09 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 122.312 1.053 . . . . 0.0 112.588 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.7 tpt180 -145.83 -80.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 58.04 -126.08 1.58 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.898 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.632 ' O ' ' O ' ' A' ' 50' ' ' ALA . 3.7 m -136.45 -145.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.068 0.461 . . . . 0.0 111.633 -178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 50' ' ' ALA . 81.3 tt0 -57.29 -42.01 80.86 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.032 -0.417 . . . . 0.0 110.877 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 34.7 p-10 -61.92 1.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.759 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 173.39 134.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -179.23 145.51 0.26 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 63' ' ' LEU . 5.1 t -104.65 154.74 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.061 0.458 . . . . 0.0 112.017 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -148.46 151.45 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.168 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -149.86 147.46 27.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.98 -175.94 3.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 0.0 111.419 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 61.66 22.09 12.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.539 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.72 41.87 1.53 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.76 -8.33 80.04 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.784 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.8 mp -66.26 -27.86 68.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.97 0.414 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.19 142.19 50.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.83 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -135.59 121.79 20.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.7 mp -115.17 130.18 56.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 52' ' ' VAL . 8.6 tp -113.58 104.96 12.77 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.964 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 38.3 tp -105.67 117.16 33.31 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt -124.41 122.23 37.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -101.98 -165.48 1.19 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.291 0.567 . . . . 0.0 112.33 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 38.24 46.02 0.84 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.726 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -75.56 109.8 9.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.403 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtt180 -101.39 -178.64 0.69 Allowed Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.1 Cg_exo -67.78 -33.89 26.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 120.974 1.116 . . . . 0.0 110.582 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -55.9 -51.93 65.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.354 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 22.5 t70 -46.36 -34.43 4.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 m -42.79 109.54 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.506 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 72' ' ' ASP . 39.4 m -155.0 -147.99 0.22 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -107.16 134.71 49.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.2 t -118.46 127.92 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -146.98 147.95 31.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.39 0.614 . . . . 0.0 111.848 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 1.6 t80 -136.19 123.67 22.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.78 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 83' ' ' MET . 12.8 tp -124.09 101.78 7.4 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -113.65 107.01 15.19 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 64.02 -165.57 30.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 54.5 t0 -60.23 26.86 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 77.6 mtm -122.1 123.78 42.38 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.04 128.83 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 110.518 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -130.31 137.01 49.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 m -153.9 141.83 20.19 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.965 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.56 159.86 43.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.188 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -79.59 161.92 25.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.075 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.4 137.79 53.48 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.711 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -135.86 122.37 20.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.09 124.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -122.75 158.03 31.06 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.825 0.345 . . . . 0.0 110.685 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.2 124.17 8.16 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.01 163.99 28.37 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.8 -68.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 110.204 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.88 -88.05 0.22 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.078 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -149.47 137.47 20.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.55 123.76 21.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.774 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -97.17 132.62 42.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.622 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.484 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 11.6 p80 -88.13 107.63 18.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 51.04 99.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.444 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 -39.5 0.73 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.539 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -174.92 136.63 0.4 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.538 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 10.2 p30 -134.94 108.39 7.86 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.425 ' N ' ' HE3' ' A' ' 83' ' ' MET . 15.8 m -151.57 109.02 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.897 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.16 133.52 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.545 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.77 -37.11 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.165 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -143.54 129.0 19.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.862 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 11' ' ' GLU . . . -90.77 -178.63 43.6 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -66.31 167.87 9.7 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -147.41 173.89 12.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.291 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.19 140.59 58.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.1 133.63 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.905 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -105.02 161.83 13.88 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.88 178.72 10.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.801 0.81 . . . . 0.0 112.131 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 mt -128.17 134.58 49.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.39 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -40.21 121.37 1.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.94 35.11 51.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.95 -151.17 9.15 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' GLU . 2.5 pm0 -133.78 -176.32 4.13 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.768 0.318 . . . . 0.0 110.734 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.22 147.21 26.72 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.396 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.96 123.49 24.72 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.57 108.61 17.39 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -103.96 113.76 27.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.112 0.482 . . . . 0.0 111.429 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.83 144.14 49.4 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.023 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.19 118.61 35.18 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 28' ' ' SER . 5.7 tt -119.13 131.04 55.85 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.747 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.5 t -87.19 93.32 9.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.567 ' C ' ' H ' ' A' ' 31' ' ' GLU . 7.5 tt0 179.95 88.01 0.19 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.447 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.97 33.83 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.717 1.611 . . . . 0.0 110.199 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 29' ' ' GLN . 79.0 tt0 -151.91 161.81 42.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 m -134.94 125.81 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.25 -38.13 5.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.3 127.42 1.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.171 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.2 OUTLIER -154.04 128.03 8.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.184 0.516 . . . . 0.0 111.18 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.4 m -120.97 129.06 53.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.958 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.6 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 1.9 t90 -114.17 123.67 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.5 mt -147.17 114.61 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.69 -110.54 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 42' ' ' GLU . 55.2 p30 -57.5 167.78 0.95 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -65.22 36.89 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 42.0 mt-10 -134.52 139.52 32.89 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.174 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.25 145.04 94.73 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.264 1.309 . . . . 0.0 110.19 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 37' ' ' TRP . 2.7 t -88.86 89.56 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.772 0.796 . . . . 0.0 112.232 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 50' ' ' ALA . 17.0 tpp180 -148.99 -91.36 0.07 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.544 ' OG1' ' N ' ' A' ' 47' ' ' SER . 3.0 p 57.77 -124.68 1.62 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.327 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.572 ' O ' ' O ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -128.38 -154.0 0.61 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.596 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' ALA . 55.3 mp0 -63.83 -35.87 82.06 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.023 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 75.1 m-20 -67.56 10.59 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.733 0.301 . . . . 0.0 111.252 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.82 125.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 176.93 146.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.55 151.55 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.53 147.31 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.896 0.379 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.529 ' CE2' ' NE2' ' A' ' 61' ' ' HIS . 7.1 m-85 -102.02 145.33 29.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.412 0.625 . . . . 0.0 112.081 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -136.4 143.09 43.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.097 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 52.75 35.93 19.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.639 0.733 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.7 t30 69.06 36.12 2.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.021 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 89.01 -8.01 80.84 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.908 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.04 -20.04 62.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -140.16 89.35 2.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.112 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 45.6 m80 -78.67 121.63 24.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 61' ' ' HIS . 8.6 mp -114.01 124.82 53.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.862 0.363 . . . . 0.0 110.083 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 63' ' ' LEU . 6.4 tt -111.04 111.44 22.55 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 63' ' ' LEU . 45.9 tp -104.13 131.85 50.99 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.16 173.42 6.33 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 6.0 ttmt -162.41 179.57 7.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 11.1 m120 38.1 40.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.925 0.393 . . . . 0.0 110.896 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.5 150.66 39.61 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.291 0.567 . . . . 0.0 111.454 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -138.19 177.89 1.92 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.44 -48.26 0.83 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.023 1.148 . . . . 0.0 110.229 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -53.7 -48.54 69.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.674 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -49.77 -36.98 27.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -48.46 131.43 17.13 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.666 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 14.9 p -172.0 -148.03 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.339 0.59 . . . . 0.0 112.49 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 77.3 ttt180 -97.15 141.07 30.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.595 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.27 125.28 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -134.47 135.1 42.22 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.371 0.605 . . . . 0.0 111.358 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.6 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.5 t80 -129.85 116.87 19.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 79' ' ' LEU . 5.8 tt -111.48 97.53 6.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.915 0.388 . . . . 0.0 111.641 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.9 90.92 3.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.203 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 50.34 -151.36 4.92 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -43.7 1.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' GLY . 2.3 mpp? -122.33 131.19 53.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.5 124.21 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.945 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -124.92 144.2 50.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.9 p -161.43 139.66 9.43 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.02 160.22 43.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -77.52 159.7 29.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.334 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.8 tp -132.09 144.14 50.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.278 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -153.36 138.91 17.75 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.062 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -128.16 118.75 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -84.29 122.42 28.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.13 126.9 2.44 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -97.05 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.9 mp -82.04 134.11 35.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -77.04 -35.84 56.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.713 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -121.29 97.42 5.5 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -105.2 -22.93 12.98 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -140.87 137.59 33.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.325 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 101' ' ' HIS . 3.3 p80 -147.99 -102.4 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.777 0.323 . . . . 0.0 110.994 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.631 ' H ' ' CG ' ' A' ' 100' ' ' HIS . 52.3 t-80 36.34 67.15 0.33 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.712 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.567 179.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 2' ' ' ALA . 90.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' N ' HG22 ' A' ' 1' ' ' THR . . . -151.83 -37.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.293 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -167.18 132.57 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 41.0 p-10 -140.59 111.2 6.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.595 ' N ' ' SD ' ' A' ' 83' ' ' MET . 85.7 m -146.23 112.51 5.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.757 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' SD ' ' A' ' 83' ' ' MET . 2.3 p -62.93 121.48 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.833 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.53 -47.46 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 2.1 ttm-85 -143.64 135.33 26.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.721 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.82 -172.63 30.42 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.04 160.51 31.95 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 8' ' ' ARG . 42.5 mt-10 -136.7 175.43 9.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.2 p-10 -61.17 143.39 55.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.965 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 23' ' ' PHE . 49.1 t -129.08 129.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -126.14 133.42 51.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.243 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.05 142.78 15.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.169 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 tp -76.84 161.39 28.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -48.47 138.66 10.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.175 0.512 . . . . 0.0 111.129 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 19.5 73.32 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -170.75 47.15 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.95 142.68 50.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -139.19 139.37 37.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' H ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -140.49 140.41 35.3 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CZ ' HG21 ' A' ' 13' ' ' VAL . 38.8 m-85 -111.43 107.35 16.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.589 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.29 108.53 21.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.28 136.11 54.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.99 113.26 26.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -117.14 131.23 56.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.916 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 28' ' ' SER . 53.9 p -96.1 90.29 5.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.173 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.636 ' HB3' HD21 ' A' ' 27' ' ' LEU . 6.7 tt0 179.27 100.44 0.16 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.59 -21.13 72.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.157 1.238 . . . . 0.0 112.945 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.85 134.77 19.01 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.616 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 34' ' ' ALA . 2.5 p -125.92 121.66 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.036 0.446 . . . . 0.0 110.666 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.78 -0.07 22.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.907 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.663 ' H ' HG22 ' A' ' 32' ' ' VAL . . . -160.08 110.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.846 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -149.89 128.98 12.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.7 m -131.63 134.45 46.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.593 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 t90 -125.43 103.24 7.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.708 0.289 . . . . 0.0 111.588 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -125.74 116.65 21.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -109.09 0.23 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -56.4 165.49 1.07 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.66 32.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 40' ' ' ASP . 30.6 mt-10 -133.9 143.56 47.99 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -54.42 134.72 62.82 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 C-N-CA 121.091 1.194 . . . . 0.0 109.558 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.1 p -86.47 83.63 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.282 1.039 . . . . 0.0 110.688 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 50' ' ' ALA . 22.9 tpt180 -146.88 -91.46 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.3 p 60.99 -128.15 0.87 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.0 m -128.63 -148.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.236 0.541 . . . . 0.0 112.141 -178.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 17.8 pt-20 -62.38 -38.7 90.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 97.8 m-20 -67.98 8.71 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.063 0.459 . . . . 0.0 111.352 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 170.35 126.46 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 177.67 149.14 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.34 152.85 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 120.58 0.229 . . . . 0.0 110.465 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.53 140.47 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -99.31 143.4 29.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.956 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -138.09 135.83 36.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.531 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 62.04 37.29 14.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.224 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 30.4 t-20 65.4 43.65 3.39 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.16 82.69 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.065 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -16.18 60.85 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -149.41 158.76 44.45 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.701 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.634 ' C ' HD12 ' A' ' 62' ' ' LEU . 42.1 m80 -143.31 130.7 21.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.027 0.441 . . . . 0.0 110.14 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.634 HD12 ' C ' ' A' ' 61' ' ' HIS . 10.6 mp -124.8 130.67 52.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.171 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.9 tp -114.23 113.72 25.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 21' ' ' ALA . 54.4 tp -113.46 127.44 56.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.325 0.584 . . . . 0.0 112.02 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 134.65 38.66 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.564 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -103.17 -164.11 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.987 0.422 . . . . 0.0 111.53 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 37.96 47.89 0.97 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.703 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.24 107.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.432 0.634 . . . . 0.0 112.693 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 14.1 mmm180 -101.13 151.75 37.75 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.236 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.51 -30.62 88.98 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.753 0.969 . . . . 0.0 110.413 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.26 -58.11 9.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.178 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' SER . 20.7 p30 -58.26 -30.04 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 6.8 p -61.91 136.8 58.12 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.454 0.57 . . . . 0.0 111.176 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 75' ' ' ARG . 21.5 p -176.48 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.411 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.59 ' N ' ' SG ' ' A' ' 74' ' ' CYS . 60.2 ttm-85 -96.82 141.37 30.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.474 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.14 128.94 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.8 m -134.1 132.12 39.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 36.8 t80 -128.68 118.97 23.78 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.478 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.26 91.18 3.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.072 0.463 . . . . 0.0 112.128 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -101.98 91.69 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.652 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 53.39 -162.19 2.96 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -48.52 -8.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.672 0.272 . . . . 0.0 111.551 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.595 ' SD ' ' N ' ' A' ' 5' ' ' THR . 55.5 mtm -101.17 124.22 46.53 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.175 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.25 132.43 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 111.484 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -126.66 134.54 50.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.069 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.6 m -150.84 139.09 20.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.819 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.91 160.22 43.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.926 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.71 162.1 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.115 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 tp -129.99 140.3 50.91 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.2 p -142.2 130.31 22.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.827 0.346 . . . . 0.0 111.286 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.4 t -141.54 128.7 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -119.01 153.48 34.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.061 0.458 . . . . 0.0 111.852 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.71 150.74 21.91 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.22 148.55 29.86 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -109.42 -34.9 6.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.872 0.368 . . . . 0.0 110.263 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 55.8 mp0 -84.78 123.14 30.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.52 -36.44 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -154.52 163.41 40.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 110.752 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -80.06 -69.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.464 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -160.67 140.36 10.92 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.523 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 46.9 p-80 -138.82 128.8 25.22 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.951 0.405 . . . . 0.0 110.522 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 101' ' ' HIS . 61.7 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.559 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' H ' ' H ' ' A' ' 3' ' ' LYS . . . -173.46 3.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.898 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 2' ' ' ALA . 1.9 tmtm? -124.64 145.43 49.65 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -134.59 108.16 7.91 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 ' N ' ' CE ' ' A' ' 83' ' ' MET . 51.9 m -147.49 111.49 5.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.009 0.433 . . . . 0.0 110.747 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.69 135.85 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.387 0.613 . . . . 0.0 110.918 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.9 t -98.63 -45.1 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -152.57 146.81 25.51 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.4 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.45 -141.45 9.6 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.121 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD13 HG12 ' A' ' 76' ' ' VAL . 79.3 mt -72.95 158.6 35.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -133.14 139.7 47.21 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 110.969 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.5 151.74 2.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.97 0.415 . . . . 0.0 110.478 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -142.24 137.67 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 2.2 pm0 -131.36 131.48 43.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.801 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.38 155.22 24.24 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.484 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.3 mp -82.12 160.15 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -40.4 153.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.086 0.47 . . . . 0.0 111.07 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.27 46.97 Favored Glycine 0 C--O 1.227 -0.291 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.88 179.22 48.67 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -124.28 156.48 36.84 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.88 138.66 37.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.542 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 mt -127.98 121.63 30.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.642 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -108.36 104.8 14.25 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.98 112.42 24.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.42 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.85 143.25 45.68 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.833 0.708 . . . . 0.0 109.61 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -106.49 124.74 50.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.244 0.545 . . . . 0.0 109.726 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD1' ' SD ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -123.15 133.24 54.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.889 -178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -105.91 87.45 2.58 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.297 0.57 . . . . 0.0 110.546 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 tt0 -172.63 84.91 0.43 Allowed Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.578 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.63 43.92 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.364 1.376 . . . . 0.0 110.553 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 29' ' ' GLN . 80.2 tt0 -150.19 149.5 30.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.283 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 32' ' ' VAL . 2.1 m -128.2 115.13 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.93 -40.32 4.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.588 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.83 127.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.76 136.0 14.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.2 m -133.05 134.52 44.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.285 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.666 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 11.3 m95 -112.79 121.02 43.47 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.0 mt -147.65 115.67 6.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.319 0.58 . . . . 0.0 112.398 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -106.77 -103.32 0.34 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 42' ' ' GLU . 40.3 p30 -62.93 166.96 5.12 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 174.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -66.44 40.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.625 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 40' ' ' ASP . 31.2 mt-10 -136.52 139.83 30.59 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 118.495 0.589 . . . . 0.0 110.699 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.73 140.72 84.81 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.094 1.196 . . . . 0.0 109.946 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' VAL . 2.4 t -86.41 83.8 2.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.328 0.585 . . . . 0.0 111.416 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 50' ' ' ALA . 48.4 ttp180 -149.99 -82.38 0.1 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 47' ' ' SER . 6.4 p 57.0 -122.15 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.552 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 50' ' ' ALA . 7.8 t -135.93 -145.82 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.847 0.356 . . . . 0.0 111.888 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 50' ' ' ALA . 84.0 tt0 -62.5 -44.28 96.75 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.64 2.87 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.591 -0.693 . . . . 0.0 112.229 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 178.86 132.55 0.08 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -179.46 147.07 0.3 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.6 t -97.81 149.75 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.317 0.579 . . . . 0.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.2 m -140.02 142.21 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 25.2 p90 -137.37 133.01 34.35 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.764 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -117.47 175.39 5.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.194 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 63.19 30.82 15.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.9 t30 64.97 41.58 4.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.871 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.23 17.53 71.47 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.803 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.8 tp -85.96 -11.32 53.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.614 0.707 . . . . 0.0 109.936 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -145.41 154.06 41.86 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.02 126.69 17.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.274 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.3 mp -124.69 132.24 53.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.464 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.97 117.83 30.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.589 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 64' ' ' LEU . 7.5 tt -105.96 125.1 50.59 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.649 0.261 . . . . 0.0 110.375 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.7 121.39 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -99.43 -165.5 1.24 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.244 0.929 . . . . 0.0 112.127 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.7 m120 35.12 44.04 0.13 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.58 110.17 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.03 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 6.7 mtt85 -102.1 -176.78 0.48 Allowed Pre-proline 0 N--CA 1.471 0.588 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 2.9 Cg_endo -69.38 -33.72 17.4 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 119.389 0.817 . . . . 0.0 110.032 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -56.74 -56.0 27.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 73' ' ' SER . 99.1 m-20 -47.18 -40.61 16.31 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.134 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 72' ' ' ASP . 38.4 t -39.43 113.31 0.32 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.091 0.86 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.3 t -156.65 -155.26 0.52 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 111.954 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -94.79 130.38 41.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.213 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 10' ' ' LEU . 15.4 t -111.21 118.21 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.1 m -132.3 128.78 38.5 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.783 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 6.6 t80 -124.48 114.87 20.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 79' ' ' LEU . 4.8 tt -115.32 94.75 4.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -103.29 88.34 3.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 53.39 -151.34 10.35 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.728 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -41.33 -13.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.554 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' GLY . 47.6 mtt -96.76 113.22 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.62 128.78 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -135.39 153.71 51.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.739 0.304 . . . . 0.0 110.664 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.5 t -155.43 127.47 7.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.539 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.81 148.29 50.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 110.222 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -80.84 165.17 22.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.73 0.776 . . . . 0.0 111.723 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.257 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -137.47 124.69 21.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.63 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.23 124.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.865 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -82.68 170.93 14.57 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -135.5 -107.76 0.92 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.9 129.27 9.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.2 mt -92.07 -50.88 5.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.283 0.541 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -144.8 -139.24 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -82.53 152.89 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -134.94 144.53 47.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.4 123.75 33.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -133.87 132.45 40.34 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 102' ' ' HIS . 15.5 t-80 -96.95 118.21 32.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.836 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 101' ' ' HIS . 44.1 t60 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.843 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.88 -35.78 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -169.61 115.71 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.036 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -139.04 107.61 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.3 m -142.89 115.09 8.38 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.767 0.318 . . . . 0.0 111.229 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 83' ' ' MET . 7.2 p -67.3 134.37 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.08 0.466 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.57 -45.62 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -151.07 153.36 34.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.186 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.82 -145.28 8.42 Favored Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.25 156.22 39.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.226 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.01 156.81 47.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.95 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 45.4 p30 -54.62 141.04 33.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.1 t -134.51 132.36 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -129.21 132.83 47.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.619 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.94 147.57 21.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.252 0.549 . . . . 0.0 111.042 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -73.08 154.15 40.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.863 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.81 137.02 13.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.79 20.96 75.54 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.71 -155.62 27.36 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.48 161.95 33.62 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.89 140.14 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.035 0.445 . . . . 0.0 110.389 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.2 mt -125.74 109.42 12.54 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.358 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -106.87 101.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 15.9 pt-20 -122.78 152.3 40.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.068 0.461 . . . . 0.0 111.025 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.75 163.62 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.961 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -114.11 108.6 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tp -110.4 131.36 55.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.769 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.3 t -84.58 97.29 9.51 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER 179.87 85.42 0.19 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.07 24.18 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.234 1.956 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 29' ' ' GLN . 81.1 tt0 -146.18 168.77 20.19 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 53.9 t -129.08 113.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.897 0.379 . . . . 0.0 109.996 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.0 -38.84 4.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.04 128.59 1.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -151.79 128.87 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.764 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.1 m -120.2 121.32 38.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.677 0.275 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE2' ' CD1' ' A' ' 78' ' ' PHE . 43.9 m95 -109.01 105.91 15.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.574 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.6 mt -135.26 110.45 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.598 0.713 . . . . 0.0 111.478 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' CD1' ' H ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -102.23 -110.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 42' ' ' GLU . 16.9 m-20 -56.8 165.84 1.11 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.04 38.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.604 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' ASP . 45.8 mt-10 -134.27 137.35 27.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.921 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.64 144.7 92.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.124 1.216 . . . . 0.0 109.986 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.6 t -91.04 86.69 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.392 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.613 ' O ' ' O ' ' A' ' 50' ' ' ALA . 63.4 mtp180 -149.13 -86.77 0.09 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.6 p 49.35 -123.58 1.89 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.153 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.552 ' O ' ' O ' ' A' ' 50' ' ' ALA . 10.2 m -127.19 -148.18 0.38 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.039 0.447 . . . . 0.0 111.734 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 50' ' ' ALA . 15.9 pt-20 -64.03 -38.55 91.48 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-20 -66.26 5.66 0.52 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.815 0.34 . . . . 0.0 111.374 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.11 128.57 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 177.88 149.72 0.19 Allowed 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.761 0.663 . . . . 0.0 109.51 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 44' ' ' VAL . 47.4 t -89.54 136.01 24.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 121.485 0.659 . . . . 0.0 111.101 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 62' ' ' LEU . 2.7 m -135.72 139.33 46.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.57 150.29 29.38 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.028 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -124.53 -178.54 4.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.891 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 56.72 25.8 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.429 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.3 m120 66.02 34.15 7.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.638 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 98.26 -7.02 61.86 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 121.236 -0.506 . . . . 0.0 113.018 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.42 -26.38 68.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.236 0.518 . . . . 0.0 109.993 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -134.5 88.25 2.43 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.558 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 52.0 m80 -79.37 107.12 11.89 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 24' ' ' GLU . 2.2 mm? -91.83 151.38 20.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.732 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 HG11 ' A' ' 44' ' ' VAL . 6.5 tt -146.89 110.53 4.92 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 64' ' ' LEU . 8.4 tt -112.58 131.81 55.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 124.98 23.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.924 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -102.25 -160.02 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.077 0.465 . . . . 0.0 111.282 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 43.57 47.38 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.763 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.68 143.74 53.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 111.254 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -141.21 151.02 60.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.737 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -52.68 -42.13 64.61 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 N-CA-C 108.774 -1.279 . . . . 0.0 108.774 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.59 -52.69 62.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.732 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 68.2 t0 -52.27 -39.39 60.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 p -48.3 132.26 16.38 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.242 0.928 . . . . 0.0 110.987 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 6.0 t -170.74 -137.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.517 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -104.85 138.03 41.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.499 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.05 121.6 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.5 m -129.28 130.11 45.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.151 0.501 . . . . 0.0 112.185 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 37' ' ' TRP . 31.4 t80 -124.78 114.65 19.54 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 tp -110.31 96.04 5.96 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.56 82.41 3.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.764 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 83' ' ' MET . . . 49.07 -145.62 6.96 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -44.01 4.11 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.631 ' N ' ' O ' ' A' ' 81' ' ' GLY . 3.3 mpp? -123.42 128.45 49.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.074 0.397 . . . . 0.0 110.129 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.87 133.13 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.0 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.3 p -137.33 150.21 47.58 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.1 t -155.0 134.52 12.63 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.231 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.63 150.92 47.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.794 0.33 . . . . 0.0 110.808 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -78.69 160.29 27.56 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.47 0.653 . . . . 0.0 111.951 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 52.0 tp -129.47 139.98 51.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.25 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.2 m -141.37 128.05 20.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.29 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -134.3 119.74 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.422 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -88.18 129.5 35.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.21 0.529 . . . . 0.0 112.176 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.02 165.74 53.62 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.05 -71.73 1.3 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.0 mm? -85.02 162.55 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -78.29 -17.44 56.61 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.182 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -93.73 127.66 39.56 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.016 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -87.6 127.62 35.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 111.183 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -134.55 111.9 10.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.0 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -121.11 143.74 48.93 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.836 0.35 . . . . 0.0 110.469 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -69.76 173.34 6.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.496 179.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.73 -25.73 1.25 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -167.35 121.07 0.97 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.906 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -142.82 109.94 5.61 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m -147.11 111.16 5.08 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.791 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' N ' ' SD ' ' A' ' 83' ' ' MET . 59.6 t -56.68 127.85 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.456 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.55 -25.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -166.94 138.3 3.28 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.53 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.8 39.13 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.13 166.27 12.08 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -137.92 166.22 24.58 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 53.0 p-10 -59.8 144.69 47.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.217 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.97 132.04 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -129.05 133.63 47.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.45 145.47 17.65 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -75.6 157.04 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 8.6 tm-20 -44.48 156.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.68 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 17' ' ' GLU . . . 56.71 19.46 28.29 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.52 -170.34 37.47 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -128.46 160.78 31.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.29 138.65 40.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 110.523 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mp -131.15 121.75 25.43 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -108.25 105.91 15.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.044 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -101.37 110.95 23.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.575 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -122.72 123.98 42.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.494 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.531 ' C ' HD13 ' A' ' 27' ' ' LEU . 78.0 mt-30 -106.98 134.45 50.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.867 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -137.19 165.18 26.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.709 0.29 . . . . 0.0 110.311 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -105.63 100.68 10.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 31' ' ' GLU . 1.7 pt20 178.22 88.72 0.15 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.66 24.38 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 111.948 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLN . 21.8 pt-20 -144.87 171.4 14.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.933 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 32' ' ' VAL . 7.1 p 151.88 115.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 124.371 1.044 . . . . 0.0 109.928 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.91 -51.56 5.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.856 0.36 . . . . 0.0 110.082 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.68 146.05 47.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.572 0.701 . . . . 0.0 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -154.9 149.07 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.543 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -110.57 113.72 26.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.13 0.49 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.622 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 9.9 m95 -111.57 102.14 10.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.407 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -131.65 112.91 12.99 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.237 0.541 . . . . 0.0 112.11 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -93.24 -107.05 0.12 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 177.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 42' ' ' GLU . 44.5 t0 -61.06 165.23 4.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -66.51 39.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.631 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 40' ' ' ASP . 34.7 mt-10 -132.37 135.0 25.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.51 137.52 72.9 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.5 p -92.92 89.21 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 122.397 1.094 . . . . 0.0 112.392 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' O ' ' A' ' 50' ' ' ALA . 28.3 tpt180 -144.74 -81.99 0.16 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 177.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.0 OUTLIER 56.52 -122.5 1.7 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.331 177.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.631 ' O ' ' O ' ' A' ' 50' ' ' ALA . 18.3 t -138.89 -144.96 0.18 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 118.118 0.417 . . . . 0.0 111.221 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 50' ' ' ALA . 91.5 mt-10 -58.06 -43.56 87.0 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.025 -0.422 . . . . 0.0 112.123 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.8 1.03 0.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.631 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 177.88 131.66 0.06 Allowed 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -177.2 140.01 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.12 141.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.325 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.54 139.27 45.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 10.2 p90 -142.45 138.48 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.354 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -132.96 -167.47 1.92 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.075 0.465 . . . . 0.0 110.273 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 65.22 27.6 12.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 62.72 45.97 5.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.384 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.42 87.77 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.507 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.83 -11.48 44.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.217 0.509 . . . . 0.0 110.77 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -129.67 140.32 51.17 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' ND1' HD11 ' A' ' 27' ' ' LEU . 68.5 m80 -128.67 105.94 8.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.153 0.501 . . . . 0.0 110.267 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.36 120.39 38.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.937 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.03 120.27 40.78 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -116.07 132.07 56.76 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 111.588 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.1 pt? -141.17 137.52 32.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -102.22 -165.4 1.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 t30 36.19 44.44 0.27 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.533 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 65' ' ' LEU . 81.3 mt -66.57 110.26 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 3.9 mtt180 -100.06 -179.25 0.79 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 4.0 Cg_exo -69.06 -32.46 21.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.261 1.308 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 -56.6 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.237 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -46.56 -40.25 12.4 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 p -41.96 117.6 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.341 0.519 . . . . 0.0 111.289 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.0 t -160.44 -145.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.711 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.73 135.91 46.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.866 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.86 123.79 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 44.6 p -136.64 132.91 35.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.238 0.542 . . . . 0.0 111.396 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 80' ' ' ALA . 3.4 t80 -122.82 115.94 22.85 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.823 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 79' ' ' LEU . 6.3 tt -118.09 92.51 3.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -104.84 95.53 5.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 60.58 -156.31 31.51 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.37 3.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.562 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 58.6 mtm -106.06 123.81 48.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.642 0.258 . . . . 0.0 111.573 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.27 138.35 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -132.59 150.66 52.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -156.52 135.0 11.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.557 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.32 157.21 43.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.055 0.455 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -78.95 161.95 26.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.78 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -129.04 140.24 51.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.173 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.4 p -137.92 124.35 20.7 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 111.222 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.3 123.19 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.743 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.0 ttp85 -104.31 140.66 37.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.775 0.321 . . . . 0.0 111.214 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.85 56.86 0.42 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.33 -88.6 0.76 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.7 tp -104.93 123.32 47.55 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -92.12 -21.1 20.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.74 125.34 34.83 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.24 -67.15 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.092 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -158.59 -46.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.773 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -129.08 149.12 51.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.625 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -151.86 157.88 42.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.492 -179.585 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.51 -2.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -124.13 147.86 47.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.307 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -135.12 107.43 7.25 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.6 m -149.93 117.57 6.18 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.054 0.454 . . . . 0.0 112.155 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' N ' ' HE3' ' A' ' 83' ' ' MET . 25.8 t -63.59 133.74 29.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.11 -35.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.784 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -138.68 123.43 18.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.123 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.64 -179.52 39.14 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.716 HD21 ' SG ' ' A' ' 25' ' ' CYS . 89.9 mt -71.92 169.48 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.448 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -139.25 169.8 17.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -61.07 148.62 39.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.2 t -131.23 131.35 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.762 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -124.14 128.02 48.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.632 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.67 18.08 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.051 0.453 . . . . 0.0 111.085 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.4 mp -73.89 159.42 32.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.75 151.04 0.31 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.118 0.485 . . . . 0.0 111.265 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.42 23.32 34.17 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.42 -178.2 41.36 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.44 151.94 32.39 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.66 154.04 25.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.783 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 152.1 36.55 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.374 0.607 . . . . 0.0 111.435 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB3' HD22 ' A' ' 10' ' ' LEU . 56.8 m-85 -120.3 110.44 16.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.273 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -107.42 123.94 49.11 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.0 0.429 . . . . 0.0 112.066 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.716 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -128.56 123.45 33.45 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -108.02 155.72 20.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -156.17 -169.77 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.845 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -118.61 95.23 4.76 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -177.95 97.69 0.22 Allowed Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.72 -16.81 54.82 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.785 1.657 . . . . 0.0 113.691 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -148.76 131.81 16.28 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.141 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 35' ' ' HIS . 6.7 p -70.33 149.05 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.822 0.82 . . . . 0.0 112.594 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.54 -40.33 4.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' C ' ' HD1' ' A' ' 35' ' ' HIS . . . -168.4 117.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.412 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.581 ' CE1' ' HB1' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -131.5 133.47 45.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.879 0.371 . . . . 0.0 111.588 -178.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.8 p -127.07 125.79 41.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.591 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.7 t90 -126.43 99.12 5.7 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.09 0.471 . . . . 0.0 112.023 -178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.8 mt -122.79 116.06 23.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.454 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -101.92 -111.18 0.22 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -50.94 164.56 0.14 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.23 34.92 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.301 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 40' ' ' ASP . 96.1 mt-10 -134.18 135.94 25.14 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.43 140.61 73.95 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 37' ' ' TRP . 7.1 p -88.21 85.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.176 0.989 . . . . 0.0 112.001 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ALA . 14.8 tpt180 -145.37 -96.21 0.1 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.5 p 62.46 -129.49 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.35 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.611 ' O ' ' O ' ' A' ' 50' ' ' ALA . 6.0 t -137.78 -143.38 0.17 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.21 0.528 . . . . 0.0 111.85 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 50' ' ' ALA . 12.8 pt-20 -54.95 -42.29 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.165 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 48.3 p-10 -63.76 3.63 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.667 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.36 132.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -178.31 140.74 0.22 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.06 143.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.005 0.431 . . . . 0.0 111.627 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.96 138.38 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -102.63 152.67 20.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.399 0.618 . . . . 0.0 111.137 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -147.15 155.13 41.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.065 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 59.51 31.24 20.87 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.11 58.02 3.27 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.39 -7.78 29.49 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.613 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.7 tp -73.57 -18.39 61.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.268 0.556 . . . . 0.0 110.31 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -134.29 144.56 48.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -126.04 107.13 10.13 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 62' ' ' LEU . 7.2 tt -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.093 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.9 tp -110.9 124.06 51.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.96 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.0 tp -102.19 130.68 48.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.651 0.738 . . . . 0.0 111.835 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.52 170.47 8.16 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.991 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -156.57 169.12 25.39 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.445 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 67' ' ' ASN . 31.8 t-20 36.28 48.41 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.187 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.47 114.29 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.149 0.5 . . . . 0.0 112.082 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 5.1 mtt85 -101.38 -178.18 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 3.3 Cg_exo -67.35 -32.29 32.99 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.013 1.142 . . . . 0.0 110.906 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.09 -52.33 61.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 73' ' ' SER . 22.1 p30 -47.27 -32.28 4.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.542 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 31.3 p -34.04 101.07 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.564 0.62 . . . . 0.0 112.021 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 94.4 m -153.03 176.06 12.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 75' ' ' ARG . 11.6 mmt-85 -88.24 152.56 21.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.221 0.534 . . . . 0.0 111.857 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.28 120.39 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -124.88 126.54 45.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.08 0.467 . . . . 0.0 110.966 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 80' ' ' ALA . 73.7 t80 -125.95 115.01 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.7 tp -111.2 93.29 4.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . . . -108.15 96.59 6.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.768 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 61.17 -162.78 22.82 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -57.34 21.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.584 ' H ' ' C ' ' A' ' 81' ' ' GLY . 1.2 mpp? -128.8 136.99 51.26 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.942 0.337 . . . . 0.0 111.353 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.72 132.14 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.954 0.407 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 p -128.39 127.25 42.25 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.6 t -150.72 149.14 29.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.957 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.28 41.34 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.215 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -81.76 168.04 18.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.533 0.683 . . . . 0.0 112.187 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 47.4 tp -124.75 137.13 54.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.513 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.5 p -132.92 118.84 19.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.59 125.08 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.223 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -108.25 143.0 37.68 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.96 130.86 2.77 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.261 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.8 101.75 2.83 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.1 mt -108.07 -18.33 13.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.07 120.0 27.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.816 0.341 . . . . 0.0 110.813 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -80.38 -66.37 0.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.22 95.66 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.198 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -112.69 -32.92 6.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.935 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.428 ' C ' ' ND1' ' A' ' 100' ' ' HIS . 1.1 p80 -85.27 169.52 13.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.647 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -134.61 153.08 52.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.458 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.603 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.68 -41.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.749 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -159.46 122.27 3.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.248 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -130.23 120.39 24.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 107.1 5.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' N ' ' SD ' ' A' ' 83' ' ' MET . 9.9 p -68.84 126.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.141 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.5 t -92.73 -36.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.849 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -146.66 131.67 18.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.511 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.61 -168.44 38.34 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.13 158.11 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 2.7 pm0 -136.81 164.29 28.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 29.6 p30 -59.33 144.75 45.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.323 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -133.63 132.97 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.81 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -132.82 123.57 26.36 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.801 0.334 . . . . 0.0 110.655 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.64 145.38 30.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 16' ' ' LEU . 9.8 mp -67.71 155.84 38.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.955 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 92' ' ' ARG . 41.7 tp10 -50.75 144.82 7.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.241 0.544 . . . . 0.0 111.586 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.98 25.23 75.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.111 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.11 -166.3 19.61 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 7.8 pm0 -124.77 174.02 8.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.53 142.38 32.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.535 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.0 mt -129.1 119.64 24.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.856 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -112.59 104.62 12.71 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 56.6 mp0 -103.13 119.5 38.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.115 0.483 . . . . 0.0 112.294 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 m -122.74 143.69 49.65 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.349 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.42 ' C ' HD13 ' A' ' 27' ' ' LEU . 73.7 mt-30 -124.89 120.86 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.003 0.43 . . . . 0.0 110.705 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.85 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.78 153.75 47.08 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.836 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -98.73 102.46 14.2 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 120.685 0.279 . . . . 0.0 111.233 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 178.37 97.46 0.15 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.61 -9.93 27.05 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.073 1.182 . . . . 0.0 111.306 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 77.7 tt0 -104.78 162.21 13.5 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 32' ' ' VAL . 3.9 p 161.45 110.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 123.821 0.7 . . . . 0.0 109.841 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.36 -43.75 5.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.781 -0.191 . . . . 0.0 111.074 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.77 141.7 51.87 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 111.27 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.18 159.79 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.304 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.6 m -115.01 91.35 3.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.823 0.344 . . . . 0.0 111.295 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.647 ' NE1' ' CD1' ' A' ' 78' ' ' PHE . 12.3 m95 -99.82 89.81 4.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.5 mt -128.76 118.2 22.41 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.93 -108.02 0.18 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 178.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' GLU . 60.8 m-20 -60.33 165.92 3.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -65.29 34.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.015 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' ASP . 50.2 mt-10 -129.94 138.84 33.98 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.44 136.48 75.9 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 CA-C-N 119.868 0.989 . . . . 0.0 109.981 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -90.47 83.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 122.37 1.081 . . . . 0.0 112.588 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' O ' ' A' ' 50' ' ' ALA . 58.3 ttp180 -147.05 -83.45 0.12 Allowed 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 47' ' ' SER . 1.2 p 58.82 -127.83 1.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 50' ' ' ALA . 23.2 t -133.68 -144.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.974 0.416 . . . . 0.0 111.517 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 50' ' ' ALA . 83.8 tt0 -57.84 -41.84 83.18 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.676 -0.64 . . . . 0.0 111.38 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 87.5 m-20 -63.97 5.57 0.22 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.432 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 45' ' ' ARG . . . 170.15 131.31 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -178.02 142.11 0.27 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 44' ' ' VAL . 5.2 t -94.44 145.1 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 121.065 0.459 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -140.13 141.67 33.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -148.78 146.66 28.14 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -120.45 176.99 5.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.964 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 60.92 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.996 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 m120 61.77 36.12 16.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.55 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 61' ' ' HIS . . . 90.0 1.33 76.43 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 121.46 -0.4 . . . . 0.0 112.916 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.87 -17.32 64.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.322 0.561 . . . . 0.0 110.122 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -142.56 95.73 2.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.86 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 58' ' ' GLY . 56.7 m80 -88.13 133.21 34.06 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.029 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.81 145.96 50.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 64' ' ' LEU . 9.0 tp -126.57 113.19 16.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.1 mp -101.93 125.96 48.72 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-O 121.045 0.45 . . . . 0.0 111.626 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 65' ' ' LEU . 91.6 mt -109.79 171.33 7.51 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -152.52 169.06 23.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.492 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 35.84 51.04 0.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 87.1 mt -59.22 113.04 1.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -97.07 153.33 38.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.518 178.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -56.44 -35.4 96.44 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 120.622 0.882 . . . . 0.0 111.088 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.96 -58.18 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -48.35 -34.59 10.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 6.2 p -44.77 128.72 6.92 Favored 'General case' 0 N--CA 1.461 0.075 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.29 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 7.1 t -169.85 -136.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.525 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -110.88 140.78 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.23 112.24 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -122.35 129.72 52.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.351 0.596 . . . . 0.0 112.606 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' CD1' ' NE1' ' A' ' 37' ' ' TRP . 6.3 t80 -130.45 119.91 23.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.4 tp -127.53 102.81 7.02 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.283 0.563 . . . . 0.0 111.857 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.454 ' HB2' ' CE1' ' A' ' 78' ' ' PHE . . . -120.82 121.47 38.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.187 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 83' ' ' MET . . . 59.78 -174.32 4.27 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -62.39 30.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 6' ' ' VAL . 27.2 mtm -127.34 127.18 43.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.95 130.21 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.389 0.614 . . . . 0.0 111.566 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -127.44 139.45 52.81 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -155.67 138.73 15.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.455 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 156.76 43.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -78.82 159.57 27.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.2 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 74' ' ' CYS . 57.6 tp -125.81 138.33 53.82 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 m -138.16 126.54 23.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.348 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.47 110.54 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 17' ' ' GLU . 85.8 mtt180 -105.69 142.25 35.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.809 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.77 20.77 6.76 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.73 159.8 40.57 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.5 tp -87.17 -75.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.859 0.362 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -78.71 144.0 35.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -108.37 124.01 49.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.333 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.69 -35.48 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.338 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 6.0 p80 -83.09 162.74 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.691 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.17 147.32 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.604 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -110.01 118.1 35.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.371 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.445 ' OXT' ' CD2' ' A' ' 102' ' ' HIS . 75.5 t60 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.414 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.93 -45.61 0.72 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 110.643 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -169.98 131.44 1.04 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.682 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -141.48 114.81 8.81 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -142.61 109.01 5.29 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.917 0.389 . . . . 0.0 110.2 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 p -65.36 129.83 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.337 0.589 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.02 -43.63 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.906 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -142.21 132.98 25.58 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.772 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.7 -177.66 42.56 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 25' ' ' CYS . 79.3 mt -75.75 167.98 20.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.718 0.294 . . . . 0.0 110.978 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -142.08 175.75 9.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 50.2 p30 -65.9 152.61 44.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.94 130.55 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.68 129.35 56.58 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 91' ' ' VAL . . . -153.14 131.63 12.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.982 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.0 157.6 37.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.467 0.651 . . . . 0.0 110.467 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -46.33 141.71 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.757 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.85 24.67 75.58 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.04 -176.02 26.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.2 pm0 -117.35 173.55 6.63 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' C ' HD22 ' A' ' 22' ' ' LEU . . . -128.55 132.3 48.25 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.362 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' C ' ' A' ' 21' ' ' ALA . 4.0 mm? -118.12 96.9 5.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.683 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -105.06 102.03 11.55 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 52.4 mp0 -107.62 123.08 47.95 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.491 0.662 . . . . 0.0 112.186 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HD21 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -130.41 130.31 44.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' HD13 ' A' ' 27' ' ' LEU . 92.9 mt-30 -115.02 125.49 53.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.066 0.46 . . . . 0.0 111.236 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.826 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -131.71 155.63 47.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.025 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -96.63 101.54 13.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.362 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 31' ' ' GLU . 4.3 pt20 -176.26 86.79 0.28 Allowed Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.66 34.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.767 1.645 . . . . 0.0 111.276 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 29' ' ' GLN . 70.2 tt0 -149.19 162.19 40.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.94 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.78 118.15 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.18 -42.15 4.01 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.127 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' C ' ' ND1' ' A' ' 35' ' ' HIS . . . -167.71 124.09 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.461 ' ND1' ' C ' ' A' ' 34' ' ' ALA . 63.5 m80 -147.52 131.16 16.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.495 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.2 m -126.47 125.86 42.81 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.49 ' CE3' ' CD1' ' A' ' 78' ' ' PHE . 2.3 t90 -115.67 123.42 48.31 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 77' ' ' THR . 95.0 mt -141.25 108.1 5.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.112 0.482 . . . . 0.0 110.96 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.74 -109.05 0.11 Allowed 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 177.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 42' ' ' GLU . 56.0 t0 -62.44 164.12 7.77 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 173.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 66.7 t0 -64.15 47.62 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' ASP . 17.1 mt-10 -137.21 139.9 29.41 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.57 142.82 99.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 N-CA-C 109.025 -1.183 . . . . 0.0 109.025 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.3 t -87.47 85.27 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.629 ' O ' ' O ' ' A' ' 50' ' ' ALA . 81.8 mtt85 -150.13 -80.96 0.11 Allowed 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 47' ' ' SER . 5.2 p 52.11 -126.05 2.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.648 ' O ' ' O ' ' A' ' 50' ' ' ALA . 4.8 t -136.26 -145.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.121 0.486 . . . . 0.0 112.211 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 50' ' ' ALA . 58.8 mp0 -54.83 -44.5 73.93 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.796 -0.565 . . . . 0.0 111.226 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 57.5 p30 -61.71 3.42 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 169.89 136.85 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.12 143.51 0.13 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.47 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' VAL . 53.2 t -92.18 144.19 9.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.37 152.93 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 53.5 p90 -136.46 -179.2 5.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.42 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CG ' ' O ' ' A' ' 54' ' ' PHE . 89.4 m-85 -159.75 176.22 12.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 58.02 35.22 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.65 0.262 . . . . 0.0 111.325 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 64.43 35.85 9.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.346 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 19.57 66.35 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.628 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.9 mt -85.78 -11.18 54.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.789 0.795 . . . . 0.0 109.572 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -129.83 134.91 47.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.239 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.58 104.16 10.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.758 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.77 124.82 51.73 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 52' ' ' VAL . 21.1 tp -116.63 117.56 30.16 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.29 133.13 49.72 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.86 177.18 4.73 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ASN . 16.0 mtpt -158.75 173.32 16.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LYS . 98.2 m-20 35.66 45.08 0.24 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.844 0.354 . . . . 0.0 110.608 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.1 mt -66.26 109.24 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -92.77 157.05 40.28 Favored Pre-proline 0 CA--C 1.52 -0.183 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.32 -32.3 25.34 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.466 -1.398 . . . . 0.0 108.466 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -52.63 -52.44 55.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.105 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.87 -40.58 21.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.938 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 3.7 m -38.52 113.46 0.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.365 0.529 . . . . 0.0 111.572 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 73' ' ' SER . 18.7 m -160.97 -169.12 2.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.118 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -82.23 139.87 34.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.578 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.11 125.76 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 38' ' ' LEU . 58.9 p -138.6 139.77 38.72 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.144 0.497 . . . . 0.0 111.706 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CD1' ' CE3' ' A' ' 37' ' ' TRP . 44.3 t80 -130.31 122.09 27.3 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.3 89.47 3.13 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.77 79.04 2.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.584 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.4 -154.71 4.1 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -40.86 -27.37 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.08 126.32 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.52 126.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.791 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -124.86 130.69 52.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.0 m -149.81 141.52 23.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.53 158.74 44.44 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.438 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 89' ' ' LEU . 43.9 t80 -84.34 172.32 11.89 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.472 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 90' ' ' THR . 4.9 tt -136.7 146.13 45.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.963 ' N ' HD23 ' A' ' 89' ' ' LEU . 21.3 p -137.05 126.99 25.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.311 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 15' ' ' ALA . 11.4 t -133.82 116.78 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.63 153.76 28.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.261 0.553 . . . . 0.0 110.955 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.94 13.01 7.22 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.13 51.32 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.621 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.6 mt -85.71 -154.27 0.2 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.662 0.268 . . . . 0.0 111.32 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.1 mp0 -77.89 124.63 28.23 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.514 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -77.44 -44.69 28.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.312 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.451 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 86.1 t60 -149.69 -1.48 0.44 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.574 0.226 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -82.18 111.83 18.65 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.29 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -122.81 140.46 52.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -152.35 155.82 38.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.016 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.283 -179.962 . . . . . . . . 0 0 . 1 stop_ save_